UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


x			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~June 29, ~~2022~~2023


o			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 1-12604


THE MARCUS CORPORATION
(Exact name of registrant as specified in its charter)


Wisconsin						39-1139844
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

100 East Wisconsin Avenue, Suite 1900 Milwaukee ,Wisconsin						53202-4125
(Address of principal executive offices)						(Zip Code)

Registrant’s telephone number, including area code: (414) 905-1000

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	MCS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.

Yes

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check One).


Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

COMMON STOCK OUTSTANDING AT ~~NOVEMBER 1, 2022~~JULY 31, 2023 – ~~24,397,417~~24,611,944

CLASS B COMMON STOCK OUTSTANDING AT ~~NOVEMBER 1, 2022 –7,110,875~~JULY 31, 2023 –7,078,410

Table of Contents

THE MARCUS CORPORATION

INDEX

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

THE MARCUS CORPORATION

Consolidated Balance Sheets

(in thousands, except share and per share data)


		September 29, 2022		December 30, 2021			June 29, 2023		December 29, 2022
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	10,529	$	17,658	Cash and cash equivalents	$	44,580	$	21,704
Restricted cash	Restricted cash	6,266		6,396		Restricted cash	4,274		2,802
Accounts receivable, net of reserves of $137 and $1,001, respectively		26,127		28,902
Government grants receivable		—		4,335
Refundable income taxes		—		22,435
Accounts receivable, net of reserves of $163 and $172, respectively						Accounts receivable, net of reserves of $163 and $172, respectively	20,591		21,455

Assets held for sale	Assets held for sale	517		4,856		Assets held for sale	558		460
Other current assets	Other current assets	17,992		15,364		Other current assets	21,579		17,474
Total current assets	Total current assets	61,431		99,946		Total current assets	91,582		63,895

Property and equipment:	Property and equipment:					Property and equipment:
Land and improvements	Land and improvements	130,057		129,642		Land and improvements	131,229		132,285
Buildings and improvements	Buildings and improvements	766,138		756,974		Buildings and improvements	730,955		729,177
Leasehold improvements	Leasehold improvements	167,579		166,060		Leasehold improvements	167,873		167,516
Furniture, fixtures and equipment	Furniture, fixtures and equipment	385,715		375,650		Furniture, fixtures and equipment	397,710		386,197
Finance lease right-of-use assets	Finance lease right-of-use assets	75,282		75,124		Finance lease right-of-use assets	29,998		29,885
Construction in progress	Construction in progress	9,476		6,000		Construction in progress	5,461		10,305
Total property and equipment	Total property and equipment	1,534,247		1,509,450		Total property and equipment	1,463,226		1,455,365
Less accumulated depreciation and amortization	Less accumulated depreciation and amortization	785,451		738,258		Less accumulated depreciation and amortization	764,048		739,600
Net property and equipment	Net property and equipment	748,796		771,192		Net property and equipment	699,178		715,765

Operating lease right-of-use assets	Operating lease right-of-use assets	205,414		217,072		Operating lease right-of-use assets	187,275		194,965

Other assets:	Other assets:					Other assets:
Investments in joint ventures	Investments in joint ventures	2,231		2,335		Investments in joint ventures	1,865		2,067
Goodwill	Goodwill	75,034		75,095		Goodwill	74,996		75,015
Deferred incomes taxes		9,903		10,032

Other	Other	13,415		12,689		Other	13,054		12,891
Total other assets	Total other assets	100,583		100,151		Total other assets	89,915		89,973
TOTAL ASSETS	TOTAL ASSETS	$	1,116,224	$	1,188,361	TOTAL ASSETS	$	1,067,950	$	1,064,598

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Balance Sheets

(in thousands, except share and per share data)


		September 29, 2022		December 30, 2021			June 29, 2023		December 29, 2022
LIABILITIES AND SHAREHOLDERS’ EQUITY	LIABILITIES AND SHAREHOLDERS’ EQUITY					LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	24,609	$	35,781	Accounts payable	$	40,636	$	32,187
Income taxes	Income taxes	218		—		Income taxes	361		—
Taxes other than income taxes	Taxes other than income taxes	18,344		19,566		Taxes other than income taxes	19,618		17,948
Accrued compensation	Accrued compensation	15,755		20,474		Accrued compensation	18,901		22,512
Other accrued liabilities	Other accrued liabilities	55,154		59,678		Other accrued liabilities	56,861		56,275
Short-term borrowings		—		47,346
Current portion of finance lease obligations	Current portion of finance lease obligations	2,485		2,561		Current portion of finance lease obligations	2,538		2,488
Current portion of operating lease obligations	Current portion of operating lease obligations	15,930		16,795		Current portion of operating lease obligations	14,596		14,553
Current maturities of long-term debt	Current maturities of long-term debt	11,095		10,967		Current maturities of long-term debt	10,391		10,432
Total current liabilities	Total current liabilities	143,590		213,168		Total current liabilities	163,902		156,395

Finance lease obligations	Finance lease obligations	15,528		17,192		Finance lease obligations	13,899		15,014

Operating lease obligations	Operating lease obligations	203,675		216,064		Operating lease obligations	187,026		195,281

Long-term debt	Long-term debt	212,530		204,177		Long-term debt	169,784		170,005

Deferred income taxes	Deferred income taxes	26,406		26,183		Deferred income taxes	27,292		26,567

Other long-term obligations	Other long-term obligations	57,267		57,963		Other long-term obligations	44,605		44,415

Equity:	Equity:					Equity:
Shareholders’ equity attributable to The Marcus Corporation	Shareholders’ equity attributable to The Marcus Corporation					Shareholders’ equity attributable to The Marcus Corporation
Preferred Stock, $1 par; authorized 1,000,000 shares; none issued	Preferred Stock, $1 par; authorized 1,000,000 shares; none issued	—		—		Preferred Stock, $1 par; authorized 1,000,000 shares; none issued	—		—
Common Stock, $1 par; authorized 50,000,000 shares; issued 24,498,243 shares at September 29, 2022 and 24,345,356 shares at December 30, 2021		24,498		24,345
Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 7,110,875 shares at September 29, 2022 and 7,130,125 shares at December 30, 2021		7,111		7,130
Common Stock, $1 par; authorized 50,000,000 shares; issued 24,691,548 shares at June 29, 2023 and 24,498,243 shares at December 29, 2022						Common Stock, $1 par; authorized 50,000,000 shares; issued 24,691,548 shares at June 29, 2023 and 24,498,243 shares at December 29, 2022	24,692		24,498
Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 7,078,410 shares at June 29, 2023 and 7,110,875 shares at December 29, 2022						Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 7,078,410 shares at June 29, 2023 and 7,110,875 shares at December 29, 2022	7,078		7,111
Capital in excess of par	Capital in excess of par	152,721		145,656		Capital in excess of par	158,231		153,794
Retained earnings	Retained earnings	285,113		289,306		Retained earnings	275,157		274,254
Accumulated other comprehensive loss	Accumulated other comprehensive loss	(10,269)		(11,444)		Accumulated other comprehensive loss	(1,797)		(1,694)
		459,174		454,993			463,361		457,963
Less cost of Common Stock in treasury (101,019 shares at September 29, 2022 and 48,111 shares at December 30, 2021)		(1,946)		(1,379)
Less cost of Common Stock in treasury (90,888 shares at June 29, 2023 and 78,882 shares at December 29, 2022)						Less cost of Common Stock in treasury (90,888 shares at June 29, 2023 and 78,882 shares at December 29, 2022)	(1,919)		(1,866)
Total shareholders’ equity attributable to The Marcus Corporation	Total shareholders’ equity attributable to The Marcus Corporation	457,228		453,614		Total shareholders’ equity attributable to The Marcus Corporation	461,442		456,097
Noncontrolling interest	Noncontrolling interest	—		—		Noncontrolling interest	—		824
Total equity	Total equity	457,228		453,614		Total equity	461,442		456,921

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,116,224	$	1,188,361	TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,067,950	$	1,064,598

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Statements of Earnings (Loss)

(in thousands, except per share data)


		13 Weeks Ended				39 Weeks Ended					13 Weeks Ended				26 Weeks Ended
		September 29, 2022		September 30, 2021		September 29, 2022		September 30, 2021			June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022
Revenues:	Revenues:									Revenues:
Theatre admissions	Theatre admissions	$	49,424	$	38,250	$	150,928	$	73,850	Theatre admissions	$	68,987	$	63,087	$	116,622	$	101,504
Rooms	Rooms	36,924		30,917		83,219		57,293		Rooms	28,646		28,865		46,503		46,295
Theatre concessions	Theatre concessions	44,715		35,952		138,326		68,932		Theatre concessions	59,707		58,147		102,082		93,611
Food and beverage	Food and beverage	21,444		16,731		54,969		32,234		Food and beverage	18,573		19,014		33,766		33,525
Other revenues	Other revenues	22,174		19,128		62,173		45,253		Other revenues	21,428		21,192		41,116		39,999
		174,681		140,978		489,615		277,562			197,341		190,305		340,089		314,934
Cost reimbursements	Cost reimbursements	8,969		4,884		24,832		11,634		Cost reimbursements	9,666		8,250		19,194		15,863
Total revenues	Total revenues	183,650		145,862		514,447		289,196		Total revenues	207,007		198,555		359,283		330,797

Costs and expenses:	Costs and expenses:									Costs and expenses:
Theatre operations	Theatre operations	54,756		40,513		160,921		87,660		Theatre operations	66,905		61,737		117,974		106,165
Rooms	Rooms	11,856		9,682		30,530		22,019		Rooms	10,360		10,471		19,638		18,674
Theatre concessions	Theatre concessions	17,868		15,094		56,054		29,627		Theatre concessions	22,601		22,993		38,331		38,186
Food and beverage	Food and beverage	16,150		12,344		43,325		25,520		Food and beverage	14,451		15,035		28,019		27,175
Advertising and marketing	Advertising and marketing	6,544		4,827		17,003		11,195		Advertising and marketing	5,613		5,978		10,678		10,459
Administrative	Administrative	19,995		16,536		56,703		45,815		Administrative	19,466		17,627		39,317		36,708
Depreciation and amortization	Depreciation and amortization	16,452		17,730		50,435		54,203		Depreciation and amortization	15,994		16,752		31,870		33,983
Rent	Rent	6,672		6,544		19,500		19,229		Rent	6,594		6,578		13,087		12,828
Property taxes	Property taxes	4,911		4,935		14,636		14,142		Property taxes	4,532		4,980		9,289		9,725
Other operating expenses	Other operating expenses	10,528		6,500		29,463		19,918		Other operating expenses	10,015		9,261		20,064		18,935
Impairment charges		—		—		—		3,732

Reimbursed costs	Reimbursed costs	8,969		4,884		24,832		11,634		Reimbursed costs	9,666		8,250		19,194		15,863
Total costs and expenses	Total costs and expenses	174,701		139,589		503,402		344,694		Total costs and expenses	186,197		179,662		347,461		328,701

Operating income (loss)		8,949		6,273		11,045		(55,498)
Operating income										Operating income	20,810		18,893		11,822		2,096

Other income (expense):	Other income (expense):									Other income (expense):
Investment income (loss)	Investment income (loss)	(35)		(7)		(762)		153		Investment income (loss)	359		(459)		619		(727)
Interest expense	Interest expense	(3,688)		(4,600)		(11,843)		(14,350)		Interest expense	(3,093)		(4,063)		(6,101)		(8,155)
Other expense		(384)		(625)		(1,545)		(1,881)
Gain (loss) on disposition of property, equipment and other assets		(88)		868		267		2,908
Equity earnings ( losses) from unconsolidated joint ventures		30		—		(104)		—
Other income (expense)										Other income (expense)	(477)		(653)		(878)		(806)
Equity earnings (losses) from unconsolidated joint ventures										Equity earnings (losses) from unconsolidated joint ventures	(31)		7		(202)		(134)
		(4,165)		(4,364)		(13,987)		(13,170)			(3,242)		(5,168)		(6,562)		(9,822)

Earnings (loss) before income taxes	Earnings (loss) before income taxes	4,784		1,909		(2,942)		(68,668)		Earnings (loss) before income taxes	17,568		13,725		5,260		(7,726)
Income tax expense ( benefit)		1,495		150		(289)		(18,931)
Income tax expense (benefit)										Income tax expense (benefit)	4,102		4,765		1,260		(1,784)
Net earnings (loss)	Net earnings (loss)	3,289		1,759		(2,653)		(49,737)		Net earnings (loss)	$	13,466	$	8,960	$	4,000	$	(5,942)
Net earnings (loss) attributable to noncontrolling interests		—		—		—		—
Net earnings (loss) attributable to The Marcus Corporation		$	3,289	1,759		$	(2,653)	$	(49,737)

Net earnings (loss) per share - basic:	Net earnings (loss) per share - basic:									Net earnings (loss) per share - basic:
Common Stock	Common Stock	$	0.11	$	0.06	$	(0.09)	$	(1.66)	Common Stock	$	0.43	$	0.29	$	0.13	$	(0.19)
Class B Common Stock	Class B Common Stock	$	0.10	$	0.05	$	(0.08)	$	(1.39)	Class B Common Stock	$	0.39	$	0.26	$	0.12	$	(0.18)

Net earnings (loss) per share - diluted:	Net earnings (loss) per share - diluted:									Net earnings (loss) per share - diluted:
Common Stock	Common Stock	$	0.10	$	0.06	$	(0.09)	$	(1.66)	Common Stock	$	0.35	$	0.24	$	0.13	$	(0.19)
Class B Common Stock	Class B Common Stock	$	0.10	$	0.05	$	(0.08)	$	(1.39)	Class B Common Stock	$	0.34	$	0.23	$	0.12	$	(0.18)

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

13 Weeks Ended 39 Weeks Ended
September 29,
2022 September 30,
2021 September 29,
2022 September 30,
2021
Net earnings (loss) $ 3,289 $ 1,759 $ (2,653) $ (49,737)
Other comprehensive income (loss), net of tax:
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect of $68, $84, $202 and $256, respectively 190 243 570 727
Fair market value adjustment of interest rate swap, net of tax effect (benefit) of $17, $(4), $133 and $0, respectively 48 (10) 377 —
Reclassification adjustment on interest rate swap included in interest expense, net of tax effect of $9, $42, $81 and $153, respectively 22 118 228 432
Other comprehensive income 260 351 1,175 1,159
Comprehensive income (loss) 3,549 2,110 (1,478) (48,578)
Comprehensive earnings (loss) attributable to noncontrolling interests — — — —
Comprehensive income (loss) attributable to The Marcus Corporation $ 3,549 $ 2,110 $ (1,478) $ (48,578)


	13 Weeks Ended				26 Weeks Ended
	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Net earnings (loss)	$	13,466	$	8,960	$	4,000	$	(5,942)
Other comprehensive income (loss), net of tax:
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect (benefit) of $(4), $67, $(9) and $134, respectively	(12)		190		(23)		380
Fair market value adjustment of interest rate swap, net of tax effect (benefit) of $0, $37, $(8) and $116, respectively	—		106		(22)		329
Reclassification adjustment on interest rate swap included in interest expense, net of tax effect (benefit) of $0, $31, $(20) and $72, respectively	—		88		(58)		206
Other comprehensive income (loss)	(12)		384		(103)		915
Comprehensive income (loss)	$	13,454	$	9,344	$	3,897	$	(5,027)

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

Consolidated Statements of Cash Flows

(in thousands)


		39 Weeks Ended					26 Weeks Ended
		September 29, 2022		September 30, 2021			June 29, 2023		June 30, 2022

OPERATING ACTIVITIES:	OPERATING ACTIVITIES:					OPERATING ACTIVITIES:
Net loss		$	(2,653)	$	(49,737)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Net income (loss)						Net income (loss)	$	4,000	$	(5,942)
Adjustments to reconcile net loss to net cash provided by operating activities:						Adjustments to reconcile net loss to net cash provided by operating activities:
Losses on investments in joint ventures	Losses on investments in joint ventures	104		—		Losses on investments in joint ventures	202		134
Gain on disposition of property, equipment and other assets		(267)		(2,908)
Impairment charges		—		3,732
(Gain) loss on disposition of property, equipment and other assets						(Gain) loss on disposition of property, equipment and other assets	777		(355)

Depreciation and amortization	Depreciation and amortization	50,435		54,203		Depreciation and amortization	31,870		33,983
Amortization of debt issuance costs	Amortization of debt issuance costs	1,242		1,784		Amortization of debt issuance costs	742		826
Share-based compensation	Share-based compensation	7,036		6,673		Share-based compensation	3,687		4,572
Deferred income taxes	Deferred income taxes	(2)		(18,817)		Deferred income taxes	780		(1,505)
Other long-term obligations	Other long-term obligations	791		2,236		Other long-term obligations	176		(49)
Contribution of the Company’s stock to savings and profit-sharing plan	Contribution of the Company’s stock to savings and profit-sharing plan	956		1,012		Contribution of the Company’s stock to savings and profit-sharing plan	1,259		956
Changes in operating assets and liabilities:	Changes in operating assets and liabilities:					Changes in operating assets and liabilities:
Accounts receivable	Accounts receivable	2,775		(12,052)		Accounts receivable	895		2,629
Government grants receivable	Government grants receivable	4,335		4,913		Government grants receivable	—		4,335
Other assets	Other assets	(3,341)		(1,552)		Other assets	(1,796)		(4,294)
Operating leases	Operating leases	(1,596)		(4,078)		Operating leases	(522)		(1,047)
Accounts payable	Accounts payable	(11,641)		7,155		Accounts payable	6,341		551
Income taxes	Income taxes	22,653		7,613		Income taxes	94		22,720
Taxes other than income taxes	Taxes other than income taxes	(1,222)		(1,031)		Taxes other than income taxes	1,670		(347)
Accrued compensation	Accrued compensation	(4,719)		5,703		Accrued compensation	(3,634)		(1,595)
Other accrued liabilities	Other accrued liabilities	(4,524)		(2,792)		Other accrued liabilities	785		(344)
Total adjustments	Total adjustments	63,015		51,794		Total adjustments	43,326		61,170
Net cash provided by operating activities	Net cash provided by operating activities	60,362		2,057		Net cash provided by operating activities	47,326		55,228

INVESTING ACTIVITIES:	INVESTING ACTIVITIES:					INVESTING ACTIVITIES:
Capital expenditures	Capital expenditures	(27,483)		(9,121)		Capital expenditures	(15,896)		(16,341)
Proceeds from disposals of property, equipment and other assets	Proceeds from disposals of property, equipment and other assets	4,850		9,160		Proceeds from disposals of property, equipment and other assets	46		4,821

Proceeds from sale of trading securities						Proceeds from sale of trading securities	17		—
Purchase of trading securities						Purchase of trading securities	(514)		—

Purchase of trading securities		—		(2,402)
Life insurance premium reimbursement		—		11,411
Other investing activities	Other investing activities	(230)		200		Other investing activities	(295)		45
Net cash provided by (used in) investing activities		(22,863)		9,248
Net cash used in investing activities						Net cash used in investing activities	(16,642)		(11,475)

FINANCING ACTIVITIES:	FINANCING ACTIVITIES:					FINANCING ACTIVITIES:
Debt transactions:	Debt transactions:					Debt transactions:
Proceeds from borrowings on revolving credit facility	Proceeds from borrowings on revolving credit facility	62,000		128,500		Proceeds from borrowings on revolving credit facility	38,000		22,000
Repayment of borrowings on revolving credit facility	Repayment of borrowings on revolving credit facility	(43,000)		(95,500)		Repayment of borrowings on revolving credit facility	(38,000)		(22,000)

Repayments on short-term borrowings	Repayments on short-term borrowings	(47,499)		(37,845)		Repayments on short-term borrowings	—		(820)
Principal payments on long-term debt	Principal payments on long-term debt	(11,275)		(10,285)		Principal payments on long-term debt	(763)		(851)
Proceeds received from borrowing on insurance policy		—		6,700

Debt issuance costs	Debt issuance costs	(37)		(208)		Debt issuance costs	(50)		—
Principal payments on finance lease obligations	Principal payments on finance lease obligations	(2,047)		(2,065)		Principal payments on finance lease obligations	(1,201)		(1,336)
Equity transactions:	Equity transactions:					Equity transactions:
Treasury stock transactions, except for stock options	Treasury stock transactions, except for stock options	(1,486)		(1,170)		Treasury stock transactions, except for stock options	(494)		(1,461)
Exercise of stock options	Exercise of stock options	126		1,455		Exercise of stock options	93		79
Dividends paid	Dividends paid	(1,540)		—		Dividends paid	(3,097)		—
Distributions to noncontrolling interest						Distributions to noncontrolling interest	(824)		—
Net cash used in financing activities	Net cash used in financing activities	(44,758)		(10,418)		Net cash used in financing activities	(6,336)		(4,389)
Net increase (decrease) in cash, cash equivalents and restricted cash		(7,259)		887
Net increase in cash, cash equivalents and restricted cash						Net increase in cash, cash equivalents and restricted cash	24,348		39,364
Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	24,054		14,088		Cash, cash equivalents and restricted cash at beginning of period	24,506		24,054
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	16,795	$	14,975	Cash, cash equivalents and restricted cash at end of period	$	48,854	$	63,418

Supplemental Information:	Supplemental Information:					Supplemental Information:
Interest paid, net of amounts capitalized	Interest paid, net of amounts capitalized	$	12,391	$	12,932	Interest paid, net of amounts capitalized	$	4,622	$	7,054
Income taxes refunded (paid), including interest earned	Income taxes refunded (paid), including interest earned	22,940		(7,733)		Income taxes refunded (paid), including interest earned	(386)		22,998
Change in accounts payable for additions to property, equipment and other assets	Change in accounts payable for additions to property, equipment and other assets	469		828		Change in accounts payable for additions to property, equipment and other assets	2,096		2,003

See accompanying condensed notes to consolidated financial statements.

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 3926 WEEKS ENDED ~~SEPTEMBER~~JUNE 29, ~~2022~~2023

(in thousands, except share and per share data)

1. General

Basis of Presentation - The unaudited consolidated financial statements for the 13 and 3926 weeks ended ~~September~~June 29, ~~2022~~2023 and ~~September~~June 30, ~~2021~~2022 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at ~~September~~June 29, ~~2022,~~2023, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December ~~30, 2021.~~29, 2022.

Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December ~~30, 2021,~~29, 2022, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies.

Noncontrolling ~~Interests~~Interest - The Company has an ownership interest greater than 50% in one joint venture that is considered a Variable Interest Entity (VIE) that is included in the accounts of the Company. The Company is the primary beneficiary of the VIE and the Company’s interest is considered a majority voting interest. The primary asset of this VIE, The Skirvin Hilton, was sold on December 16, 2022. The equity interest of outside owners in consolidated entities is recorded as noncontrolling ~~interests~~interest in the consolidated balance sheets, and their share of earnings is recorded as net earnings (loss) attributable to noncontrolling interests in the consolidated statements of earnings (loss) in accordance with the partnership agreement. Due to the cumulative losses of the entity, the noncontrolling interest balance is $0 as of September 29, 2022 and December 30, 2021. The Company will not record earnings or losses from noncontrolling interest until the entity returns to profitability.sheets.

Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled ~~$16,444~~$15,986 and ~~$50,411~~$31,854 for the 13 and 3926 weeks ended ~~September~~June 29, ~~2022,~~2023, respectively, and ~~$17,714~~$16,744 and ~~$54,147~~$33,967 for the 13 and 3926 weeks ended ~~September~~June 30, ~~2021,~~2022, respectively.

Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset. As of ~~September~~June 29, ~~2022,~~2023, assets held for sale consists of excess land.

~~Insurance Policies -~~ During the 13 weeks ended September 30, 2021, the Company received $6,700 of loan proceeds, recorded against the cash surrender value of a key-man life insurance policy. The loan bears interest at 8.0% which is payable annually. The loan is netted against the value of the life insurance policy and is included in other long-term assets in the consolidated balance sheet. Also during the 13 weeks ended September 30, 2021, the Company received $11,400 as reimbursement on a split dollar life insurance policy.

Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value. During the 39 weeks ended September 30, 2021, the Company determined that indicators of impairment were present for certain assets. As such, the Company evaluated the value of its property and equipment and the value of its operating lease right-of-use-assets and recorded an impairment charge as discussed in Note 3. There were no indicators of impairment identified during the 3926 weeks ended ~~September~~June 29, 2023 or June 30, 2022.

Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 3926 weeks ended ~~September~~June 29, ~~2022~~2023 or ~~September~~June 30, ~~2021.~~2022.

Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.

Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.

The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:


		13 Weeks Ended				39 Weeks Ended					13 Weeks Ended				26 Weeks Ended
		September 29, 2022		September 30, 2021		September 29, 2022		September 30, 2021			June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Numerator:	Numerator:									Numerator:
Net earnings (loss) attributable to The Marcus Corporation		$	3,289	$	1,759	$	(2,653)	$	(49,737)
Denominator:
Net earnings (loss)										Net earnings (loss)	$	13,466	$	8,960	$	4,000	$	(5,942)
Denominator (in thousands):										Denominator (in thousands):
Denominator for basic EPS	Denominator for basic EPS	31,506		31,421		31,481		31,340		Denominator for basic EPS	31,673		31,492		31,622		31,469
Effect of dilutive employee stock options	Effect of dilutive employee stock options	84		48		—		—		Effect of dilutive employee stock options	61		40		52		—
Effect of convertible notes	Effect of convertible notes	9,112		—		—		—		Effect of convertible notes	9,201		9,085		—		—
Denominator for diluted EPS	Denominator for diluted EPS	40,702		31,469		31,481		31,340		Denominator for diluted EPS	40,935		40,617		31,674		31,469
Net earnings (loss) per share - basic:	Net earnings (loss) per share - basic:									Net earnings (loss) per share - basic:
Common Stock	Common Stock	$	0.11	$	0.06	$	(0.09)	$	(1.66)	Common Stock	$	0.43	$	0.29	$	0.13	$	(0.19)
Class B Common Stock	Class B Common Stock	$	0.10	$	0.05	$	(0.08)	$	(1.39)	Class B Common Stock	$	0.39	$	0.26	$	0.12	$	(0.18)
Net earnings (loss) per share - diluted:	Net earnings (loss) per share - diluted:									Net earnings (loss) per share - diluted:
Common Stock	Common Stock	$	0.10	$	0.06	$	(0.09)	$	(1.66)	Common Stock	$	0.35	$	0.24	$	0.13	$	(0.19)
Class B Common Stock	Class B Common Stock	$	0.10	$	0.05	$	(0.08)	$	(1.39)	Class B Common Stock	$	0.34	$	0.23	$	0.12	$	(0.18)

For the periods when the Company reports a net loss, common stock equivalents are excluded from the computation of diluted loss per share as their inclusion would have an antidilutive effect. During the 3926 weeks ended ~~September 29,~~June 30, 2022, ~~and September 30, 2021,~~ approximately ~~76,714 and 104,146~~61,791 common stock equivalents ~~respectively,~~ were excluded from the computation of diluted loss per share due to the Company’s net loss. During the 3926 weeks ended ~~September~~June 29, 2023, and June 30, 2022, ~~9,111,846~~respectively, 9,200,907 and 9,084,924 shares related to the convertible notes were excluded from the computation of diluted loss per share as the effect would have been anti-dilutive. During the 13 and 39 weeks ended September 30, 2021, 9,084,924 shares related to the convertible notes were excluded from the computation of diluted income (loss) per share as the effect would have been anti-dilutive.

Shareholders’ Equity - Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 13 and 3926 weeks ended ~~September~~June 29, ~~2022~~2023 and ~~September~~June 30, ~~2021~~2022 was as follows:


		Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity			Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 30, 2021		$	24,345	$	7,130	$	145,656	$	289,306	$	(11,444)	$	(1,379)	$	453,614	$	—	$	453,614
BALANCES AT DECEMBER 29, 2022																				BALANCES AT DECEMBER 29, 2022	$	24,498	$	7,111	$	153,794	$	274,254	$	(1,694)	$	(1,866)	$	456,097	$	824	$	456,921
Cash dividends:																				Cash dividends:
$0.045 per share Class B Common Stock																				$0.045 per share Class B Common Stock	—		—		—		(319)		—		—		(319)		—		(319)
$0.05 per share Common Stock																				$0.05 per share Common Stock	—		—		—		(1,229)		—		—		(1,229)		—		(1,229)
Exercise of stock options	Exercise of stock options	—		—		(5)		—		—		31		26		—		26		Exercise of stock options	—		—		(1)		—		—		3		2		—		2
Purchase of treasury stock	Purchase of treasury stock	—		—		—		—		—		(1,373)		(1,373)		—		(1,373)		Purchase of treasury stock	—		—		—		—		—		(313)		(313)		—		(313)
Savings and profit-sharing contribution	Savings and profit-sharing contribution	56		—		900		—		—		—		956		—		956		Savings and profit-sharing contribution	79		—		1,180		—		—		—		1,259		—		1,259
Reissuance of treasury stock	Reissuance of treasury stock	—		—		1		—		—		8		9		—		9		Reissuance of treasury stock	—		—		(3)		—		—		24		21		—		21
Issuance of non-vested stock	Issuance of non-vested stock	78		—		(236)		—		—		158		—		—		—		Issuance of non-vested stock	82		—		(143)		—		—		61		—		—		—
Shared-based compensation	Shared-based compensation	—		—		2,917		—		—		—		2,917		—		2,917		Shared-based compensation	—		—		2,172		—		—		—		2,172		—		2,172
Other	Other	—		—		1		(1)		—		—		—		—		—		Other	—		—		1		(1)		—		—		—		—		—
Conversions of Class B Common Stock	Conversions of Class B Common Stock	19		(19)		—		—		—		—		—		—		—		Conversions of Class B Common Stock	33		(33)		—		—		—		—		—		—		—
Comprehensive income (loss)		—		—		—		(14,902)		531		—		(14,371)		—		(14,371)
BALANCES AT MARCH 31, 2022		$	24,498	$	7,111	$	149,234	$	274,403	$	(10,913)	$	(2,555)	$	441,778	$	—	$	441,778
Exercise of stock options		—		—		(16)		—		—		69		53		—		53
Purchase of treasury stock		—		—		—		—		—		(104)		(104)		—		(104)
Reissuance of treasury stock		—		—		(2)		—		—		9		7		—		7
Issuance of non-vested stock		—		—		(305)		—		—		305		—		—		—
Shared-based compensation		—		—		1,655		—		—		—		1,655		—		1,655
Other		—		—		(1)		1		—		—		—		—		—
Comprehensive income		—		—		—		8,960		384		—		9,344		—		9,344
BALANCES AT JUNE 30, 2022		$	24,498	$	7,111	$	150,565	$	283,364	$	(10,529)	$	(2,276)	$	452,733	$	—	$	452,733
Distribution to noncontrolling interest																				Distribution to noncontrolling interest	—		—		—		—		—		—		—		(550)		(550)
Comprehensive loss																				Comprehensive loss	—		—		—		(9,466)		(91)		—		(9,557)		—		(9,557)
BALANCES AT MARCH 30, 2023																				BALANCES AT MARCH 30, 2023	$	24,692	$	7,078	$	157,000	$	263,239	$	(1,785)	$	(2,091)	$	448,133	$	274	$	448,407
Cash dividends:	Cash dividends:																			Cash dividends:
$0.045 per share Class B Common Stock	$0.045 per share Class B Common Stock	—		—		—		(320)		—		—		(320)		—		(320)		$0.045 per share Class B Common Stock	—		—		—		(319)		—		—		(319)		—		(319)
$0.05 per share Common Stock	$0.05 per share Common Stock	—		—		—		(1,220)		—		—		(1,220)		—		(1,220)		$0.05 per share Common Stock	—		—		—		(1,230)		—		—		(1,230)		—		(1,230)
Exercise of stock options	Exercise of stock options	—		—		(175)		—		—		988		813		—		813		Exercise of stock options	—		—		(25)		—		—		121		96		—		96
Purchase of treasury stock	Purchase of treasury stock	—		—		—		—		—		(809)		(809)		—		(809)		Purchase of treasury stock	—		—		—		—		—		(226)		(226)		—		(226)
Reissuance of treasury stock	Reissuance of treasury stock	—		—		(2)		—		—		20		18		—		18		Reissuance of treasury stock	—		—		(204)		—		—		223		19		—		19
Issuance of non-vested stock	Issuance of non-vested stock	—		—		(131)		—		—		131		—		—		—		Issuance of non-vested stock	—		—		(55)		—		—		55		—		—		—
Shared-based compensation	Shared-based compensation	—		—		2,464		—		—		—		2,464		—		2,464		Shared-based compensation	—		—		1,515		—		—		—		1,515		—		1,515
Comprehensive income		—		—		—		3,289		260		—		3,549		—		3,549
BALANCES AT SEPTEMBER 29, 2022		$	24,498	$	7,111	$	152,721	$	285,113	$	(10,269)	$	(1,946)	$	457,228	$	—	$	457,228
Other																				Other	—		—		—		1		—		(1)		—		—		—
Distribution to noncontrolling interest																				Distribution to noncontrolling interest	—		—		—		—		—		—		—		(274)		(274)
Comprehensive income (loss)																				Comprehensive income (loss)	—		—		—		13,466		(12)		—		13,454		—		13,454
BALANCES AT JUNE 29, 2023																				BALANCES AT JUNE 29, 2023	$	24,692	$	7,078	$	158,231	$	275,157	$	(1,797)	$	(1,919)	$	461,442	$	—	$	461,442


		Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity			Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 31, 2020		$	23,264	$	7,926	$	153,529	$	331,897	$	(14,933)	$	(2,960)	$	498,723	$	—	$	498,723
Adoption of ASU No. 2020-06		—		—		(16,511)		702		—		—		(15,809)		—		(15,809)
BALANCES AT DECEMBER 30, 2021																				BALANCES AT DECEMBER 30, 2021	$	24,345	$	7,130	$	145,656	$	289,306	$	(11,444)	$	(1,379)	$	453,614	$	—	$	453,614
Exercise of stock options	Exercise of stock options	—		—		(659)		—		—		1,951		1,292		—		1,292		Exercise of stock options	—		—		(5)		—		—		31		26		—		26
Purchase of treasury stock	Purchase of treasury stock	—		—		—		—		—		(1,181)		(1,181)		—		(1,181)		Purchase of treasury stock	—		—		—		—		—		(1,373)		(1,373)		—		(1,373)
Savings and profit-sharing contribution	Savings and profit-sharing contribution	44		—		968		—		—		—		1,012		—		1,012		Savings and profit-sharing contribution	56		—		900		—		—		—		956		—		956
Reissuance of treasury stock	Reissuance of treasury stock	—		—		2		—		—		10		12		—		12		Reissuance of treasury stock	—		—		1		—		—		8		9		—		9
Issuance of non-vested stock	Issuance of non-vested stock	221		—		(367)		—		—		146		—		—		—		Issuance of non-vested stock	78		—		(236)		—		—		158		—		—		—
Shared-based compensation	Shared-based compensation	—		—		1,484		—		—		—		1,484		—		1,484		Shared-based compensation	—		—		2,917		—		—		—		2,917		—		2,917
Other	Other	—		—		—		(1)		—		1		—		—		—		Other	—		—		1		(1)		—		—		—		—		—
Conversions of Class B Common Stock	Conversions of Class B Common Stock	520		(520)		—		—		—		—		—		—		—		Conversions of Class B Common Stock	19		(19)		—		—		—		—		—		—		—
Comprehensive income (loss)	Comprehensive income (loss)	—		—		—		(28,130)		452		—		(27,678)		—		(27,678)		Comprehensive income (loss)	—		—		—		(14,902)		531		—		(14,371)		—		(14,371)
BALANCES AT APRIL 1, 2021		$	24,049	$	7,406	$	138,446	$	304,468	$	(14,481)	$	(2,033)	$	457,855	$	—	$	457,855
BALANCES AT MARCH 31, 2022																				BALANCES AT MARCH 31, 2022	$	24,498	$	7,111	$	149,234	$	274,403	$	(10,913)	$	(2,555)	$	441,778	$	—	$	441,778
Exercise of stock options	Exercise of stock options	—		—		(40)		—		—		122		82		—		82		Exercise of stock options	—		—		(16)		—		—		69		53		—		53
Purchase of treasury stock	Purchase of treasury stock	—		—		—		—		—		(73)		(73)		—		(73)		Purchase of treasury stock	—		—		—		—		—		(104)		(104)		—		(104)
Reissuance of treasury stock	Reissuance of treasury stock	—		—		(1)		—		—		7		6		—		6		Reissuance of treasury stock	—		—		(2)		—		—		9		7		—		7
Issuance of non-vested stock	Issuance of non-vested stock	18		—		(157)		—		—		139		—		—		—		Issuance of non-vested stock	—		—		(305)		—		—		305		—		—		—
Shared-based compensation	Shared-based compensation	—		—		2,668		—		—		—		2,668		—		2,668		Shared-based compensation	—		—		1,655		—		—		—		1,655		—		1,655
Conversions of Class B Common Stock		275		(275)		—		—		—		—		—		—		—
Comprehensive income (loss)		—		—		—		(23,366)		356		—		(23,010)		—		(23,010)
BALANCES AT JULY 1, 2021		$	24,342	$	7,131	$	140,916	$	281,102	$	(14,125)	$	(1,838)	$	437,528	$	—	$	437,528
Exercise of stock options		—		—		(44)		—		—		125		81		—		81
Purchase of treasury stock		—		—		—		—		—		(60)		(60)		—		(60)
Reissuance of treasury stock		—		—		20		—		—		106		126		—		126
Forfeitures of non-vested stock		(2)		—		(137)		—		—		139		—		—		—
Shared-based compensation		—		—		2,521		—		—		—		2,521		—		2,521

Comprehensive income	Comprehensive income	—		—		—		1,759		351		—		2,110		—		2,110		Comprehensive income	—		—		—		8,960		384		—		9,344		—		9,344
BALANCES AT SEPTEMBER 30, 2021		$	24,340	$	7,131	$	143,276	$	282,861	$	(13,774)	$	(1,528)	$	442,306	$	—	$	442,306
BALANCES AT JUNE 30, 2022																				BALANCES AT JUNE 30, 2022	$	24,498	$	7,111	$	150,565	$	283,364	$	(10,529)	$	(2,276)	$	452,733	$	—	$	452,733

Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:


		September 29, 2022		December 30, 2021			June 29, 2023		December 29, 2022

Unrecognized gain (loss) on interest rate swap agreements		$	96	$	(509)
Unrecognized gain on interest rate swap agreements						Unrecognized gain on interest rate swap agreements	$	—	$	80
Net unrecognized actuarial loss for pension obligation	Net unrecognized actuarial loss for pension obligation	(10,365)		$	(10,935)	Net unrecognized actuarial loss for pension obligation	(1,797)		$	(1,774)
		$	(10,269)	$	(11,444)		$	(1,797)	$	(1,694)

Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.

The Company’s assets and liabilities measured at fair value are classified in one of the following categories:

Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At ~~September~~June 29, ~~2022~~2023 and December ~~30, 2021,~~29, 2022, respectively, the Company’s ~~$3,647~~$4,894 and ~~$4,617~~$3,932 of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At June 29, 2023 and December ~~30, 2021,~~29, 2022, respectively, the Company’s ~~$5,000~~$34,999 and $6,000 of investments in money market ~~accounts~~funds were valued using Level 1 pricing inputs and were included in cash and cash equivalents. ~~The Company had no investments in money market accounts at September 29, 2022.~~

Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At ~~September~~December 29, 2022, ~~and December 30, 2021, respectively,~~ the Company’s ~~$130~~$108 asset ~~and $689 liability~~ related to the Company’s interest rate swap contract was valued using Level 2 pricing inputs. This contracted terminated on March 1, 2023.

Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At ~~September~~June 29, ~~2022~~2023 and December ~~30, 2021,~~29, 2022, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. ~~Assets and liabilities that were measured on a non-recurring basis are discussed in Note 3.~~

The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $80,000 of senior notes, valued using Level 2 pricing inputs, is approximately ~~$69,192~~$72,187 at ~~September~~June 29, ~~2022,~~2023, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The fair value of the Company's $100,050 of convertible senior notes, valued using Level 2 pricing inputs, is approximately ~~$152,963~~$150,020 at ~~September~~June 29, ~~2022,~~2023, determined based on market rates and the closing trading price of the convertible senior notes as of ~~September~~June 29, ~~2022.~~2023. The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.

Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:


		13 Weeks Ended				39 Weeks Ended					13 Weeks Ended				26 Weeks Ended
		September 29, 2022		September 30, 2021		September 29, 2022		September 30, 2021			June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Service cost	Service cost	$	263	$	278	$	791	$	839	Service cost	$	122	$	264	$	244	$	528
Interest cost	Interest cost	335		300		1,005		901		Interest cost	452		335		905		670
Net amortization of prior service cost and actuarial loss	Net amortization of prior service cost and actuarial loss	258		331		772		986		Net amortization of prior service cost and actuarial loss	(16)		257		(32)		514
Net periodic pension cost	Net periodic pension cost	$	856	$	909	$	2,568	$	2,726	Net periodic pension cost	$	558	$	856	$	1,117	$	1,712

Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.

Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 3926 weeks ended ~~September~~June 29, ~~2022~~2023 is as follows:


		13 Weeks Ended September 29, 2022									13 Weeks Ended June 29, 2023
		Theatres		Hotels/Resorts		Corporate		Total			Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	Theatre admissions	$	49,424	$	—	$	—	$	49,424	Theatre admissions	$	68,987	$	—	$	—	$	68,987
Rooms	Rooms	—		36,924		—		36,924		Rooms	—		28,646		—		28,646
Theatre concessions	Theatre concessions	44,715		—		—		44,715		Theatre concessions	59,707		—		—		59,707
Food and beverage	Food and beverage	—		21,444		—		21,444		Food and beverage	—		18,573		—		18,573
Other revenues(1)	Other revenues(1)	7,119		14,963		92		22,174		Other revenues(1)	8,156		13,181		91		21,428
Cost reimbursements	Cost reimbursements	—		8,969		—		8,969		Cost reimbursements	—		9,666		—		9,666
Total revenues	Total revenues	$	101,258	$	82,300	$	92	$	183,650	Total revenues	$	136,850	$	70,066	$	91	$	207,007

		39 Weeks Ended September 29, 2022
		Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions		$	150,928	$	—	$	—	$	150,928
Rooms		—		83,219		—		83,219
Theatre concessions		138,326		—		—		138,326
Food and beverage		—		54,969		—		54,969
Other revenues(1)		20,932		40,938		303		62,173
Cost reimbursements		—		24,832		—		24,832
Total revenues		$	310,186	$	203,958	$	303	$	514,447


	26 Weeks Ended June 29, 2023
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	116,622	$	—	$	—	$	116,622
Rooms	—		46,503		—		$	46,503
Theatre concessions	102,082		—		—		$	102,082
Food and beverage	—		33,766		—		$	33,766
Other revenues(1)	14,522		26,414		180		$	41,116
Cost reimbursements	—		19,194		—		$	19,194
Total revenues	$	233,226	$	125,877	$	180	$	359,283

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The disaggregation of revenues by business segment for the 13 and 3926 weeks ended ~~September~~June 30, ~~2021~~2022 is as follows:


		13 Weeks Ended September 30, 2021									13 Weeks Ended June 30, 2022
		Theatres		Hotels/Resorts		Corporate		Total			Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	Theatre admissions	$	38,250	$	—	$	—	$	38,250	Theatre admissions	$	63,087	$	—	$	—	$	63,087
Rooms	Rooms	—		30,917		—		30,917		Rooms	—		28,865		—		28,865
Theatre concessions	Theatre concessions	35,952		—		—		35,952		Theatre concessions	58,147		—		—		58,147
Food and beverage	Food and beverage	—		16,731		—		16,731		Food and beverage	—		19,014		—		19,014
Other revenues(1)	Other revenues(1)	5,793		13,272		63		19,128		Other revenues(1)	8,203		12,872		117		21,192
Cost reimbursements	Cost reimbursements	1		4,883		—		4,884		Cost reimbursements	—		8,250		—		8,250
Total revenues	Total revenues	$	79,996	$	65,803	$	63	$	145,862	Total revenues	$	129,437	$	69,001	$	117	$	198,555

		39 Weeks Ended September 30, 2021
		Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions		$	73,850	$	—	$	—	$	73,850
Rooms		—		57,293		—		57,293
Theatre concessions		68,932		—		—		68,932
Food and beverage		—		32,234		—		32,234
Other revenues(1)		11,989		33,006		258		45,253
Cost reimbursements		88		11,546		—		11,634
Total revenues		$	154,859	$	134,079	$	258	$	289,196


	26 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	101,504	$	—	$	—	$	101,504
Rooms	—		46,295		—		46,295
Theatre concessions	93,611		—		—		93,611
Food and beverage	—		33,525		—		33,525
Other revenues(1)	13,813		25,975		211		39,999
Cost reimbursements	—		15,863		—		15,863
Total revenues	$	208,928	$	121,658	$	211	$	330,797

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The Company had deferred revenue from contracts with customers of ~~$35,413~~$37,670 and ~~$39,144~~$37,046 as of ~~September~~June 29, ~~2022~~2023 and December ~~30, 2021,~~29, 2022, respectively. The Company had no contract assets as of ~~September~~June 29, ~~2022~~2023 and December ~~30, 2021.~~29, 2022. During the 3926 weeks ended ~~September~~June 29, 2023, the Company recognized revenue of $10,875 that was included in deferred revenues as of December 29, 2022. During the 26 weeks ended June 30, 2022, the Company recognized revenue of ~~$12,273~~$9,448 that was included in deferred revenues as of December 30, 2021. ~~During the 39 weeks ended September 30, 2021, the Company recognized revenue of $8,394 that was included in deferred revenues as of December 31, 2020.~~ The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.

As of ~~September~~June 29, ~~2022,~~2023, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was ~~$3,123~~$1,980 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of June 29, 2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $16,318 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years.

As of ~~September~~June 29, ~~2022,~~2023, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was ~~$3,464~~$3,834 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.

The majority of the Company’s revenue is recognized in less than one year from the original contract.

~~New Accounting Pronouncements~~ ~~– During the first quarter of fiscal 2022, the Company adopted Accounting Standards Update (ASU) No. 2021-10,~~ ~~Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance~~. The amendments in this update provide increased transparency of government assistance including the requirement of certain disclosures in a company’s notes to the consolidated financial statements about transactions with a

~~government. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.~~

~~In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04,~~ ~~Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.~~ The amendments in this update provide optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (LIBOR), or other interbank offered rates, to alternative reference rates such as the Secured Overnight Financing Rate (SOFR). ASU No. 2020-14 is optional, effective immediately, and may be elected over time as reference rate reform activities occur, generally through December 31, 2022. The Company will evaluate the effect the new standard will have on its consolidated financial statements when a replacement rate is chosen.

2. ~~Impact of COVID-19 Pandemic~~

The COVID-19 pandemic has had an unprecedented impact on the world and both of the Company’s business segments. As an operator of movie theatres, hotels and resorts, restaurants and bars, each of which consists of spaces where customers and guests gather in close proximity, the Company’s businesses were significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic, and the customers’ reactions or responses to such actions. The extent of these protective actions and their impact on the Company’s businesses has continued to dissipate during the first three quarters of fiscal 2022.

The Company began fiscal 2022 with all of its theatres open with normal operating days and hours. While still below pre-COVID-19 levels, attendance has continued to gradually improve as the number of vaccinated individuals increased, more films are released, and customers indicate increasing willingness to return to movie theatres.

The Company began fiscal 2022 with all eight of its company-owned and managed hotels open. All of the Company’s restaurants and bars in its hotels and resorts were open during the third quarter of fiscal 2022, operating in some cases with reduced operating hours. The majority of the Company’s hotels and restaurants are now generating revenues at or above pre-pandemic levels.

Since the COVID-19 pandemic began, the Company has been working proactively to preserve cash and enhance liquidity. As of September 29, 2022, the Company had cash and cash equivalents of approximately $10,529 and $202,809 of availability under its $225,000 revolving credit facility. With this strong liquidity position, combined with cash generated from operations and proceeds from the sale of surplus real estate, the Company believes it is positioned to meet its obligations as they come due and continue to sustain its operations throughout fiscal 2022 and 2023, even if the properties continue to generate reduced revenues during these periods.

During the first three quarters of fiscal 2022, the Company received a $22,959 federal income tax refund (including $636 of interest) related to its fiscal 2020 tax return, with the primary benefit derived from net operating loss carrybacks to prior years. The Company also received $4,335 in state theatre grants during the first three quarters of fiscal 2022 that were awarded and accrued during the fourth quarter of fiscal 2021.

The Company believes that the actions that have been taken will allow it to have sufficient liquidity to meet its obligations as they come due and to comply with its debt covenants for at least 12 months from the issuance date of these unaudited consolidated financial statements. However, future compliance with the Company’s debt covenants are dependent upon the timing of new movie releases and the protective actions that federal, state and local governments have taken which impact consumer confidence and the speed of recovery of the Company’s theatres and hotels and resorts businesses. The Company’s estimates and assumptions related to future forecasted results of the Company are subject to inherent risk and uncertainty due to the ongoing impact of the COVID-19 pandemic, and actual results could differ materially from estimated amounts and impact the Company’s ability to comply with its debt covenants.

~~Table of Contents~~

~~THE MARCUS CORPORATION~~

~~CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 29, 2022~~

~~(in thousands, except share and per share data)~~

~~3. Impairment Charges~~

During the 39 weeks ended September 30, 2021, the Company determined that indicators of impairment were evident at certain theatre asset groups. For certain of the theatre asset groups evaluated for impairment, the sum of the estimated undiscounted future cash flows attributable to these assets was less than their carrying amount. The Company evaluated the fair value of these assets, consisting primarily of leasehold improvements, furniture, fixtures and equipment, and operating lease right-of-use-assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset, including estimated sales proceeds) was less than their carrying values and recorded a $3,732 impairment loss, reducing certain property and equipment and certain operating lease right-of-use assets. The remaining net book value of the impaired assets as of the date of the asset write-down (July 1, 2021) was $10,200, excluding any applicable remaining lease obligations. There were no indicators of impairment identified during the 39 weeks ended September 29, 2022.

4. Long-Term Debt ~~and Short-Term Borrowings~~

Long-term debt ~~and short-term borrowings are~~is summarized as follows:


		September 29, 2022		December 30, 2021			June 29, 2023		December 29, 2022

Mortgage notes		$	24,112	$	24,388

Senior notes	Senior notes	80,000		90,000		Senior notes	$	80,000	$	80,000
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	1,056		1,356		Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	744		954
Convertible senior notes	Convertible senior notes	100,050		100,050		Convertible senior notes	100,050		100,050
Payroll Protection Program loans	Payroll Protection Program loans	2,481		3,181		Payroll Protection Program loans	1,687		2,240
Revolving credit agreement	Revolving credit agreement	19,000		—		Revolving credit agreement	—		—
Debt issuance costs	Debt issuance costs	(3,074)		(3,831)		Debt issuance costs	(2,306)		(2,807)
Total debt, net of debt issuance costs	Total debt, net of debt issuance costs	223,625		215,144		Total debt, net of debt issuance costs	180,175		180,437
Less current maturities, net of issuance costs	Less current maturities, net of issuance costs	11,095		10,967		Less current maturities, net of issuance costs	10,391		10,432
Long-term debt	Long-term debt	$	212,530	204,177		Long-term debt	$	169,784	$	170,005

Short-term borrowings		—		47,346
Total debt and short-term borrowings, net of issuance costs		$	223,625	$	262,490

Credit Agreement ~~and Short-Term Borrowings~~

On January 9, 2020, the Company replaced its then-existing credit agreement with several banks. On April 29, 2020, the Company entered into the First Amendment, on September 15, 2020, the Company entered into the Second Amendment, on July 13, 2021, the Company entered into the Third Amendment, ~~and~~ on July 29, 2022, the Company entered into the Fourth Amendment and on February 10, 2023, the Company entered into the Fifth Amendment (the Credit Agreement, as amended by the First Amendment, the Second Amendment, the Third Amendment, the Fourth Amendment and the ~~Fourth~~Fifth Amendment, hereinafter referred to as the “Credit Agreement”).

The Credit Agreement provides for a revolving credit facility that matures on January 9, 2025 with an initial maximum aggregate amount of availability of $225,000. At ~~September~~June 29, ~~2022,~~2023, there were borrowings of ~~$19,000~~$0 outstanding on the revolving credit facility, which when borrowed, bear interest at ~~LIBOR~~the secured overnight financing rate (“SOFR”) plus a margin, effectively ~~6.70%~~6.22% at ~~September~~June 29, ~~2022.~~2023. Availability under the line at ~~September~~June 29, ~~2022,~~2023, was ~~$202,809,~~$220,623, after taking into consideration outstanding letters of credit that reduce revolver availability.

~~In conjunction~~Effective with the ~~First~~Fifth Amendment on February 10, 2023, the ~~Company added an initial $90,800 term loan facility that~~variable rate LIBOR benchmark in the Credit Agreement was ~~scheduled to mature on September 22, 2021. In conjunction~~replaced with ~~the Third Amendment, the term loan facility was reduced to $50,000~~

~~Table of Contents~~

~~THE MARCUS CORPORATION~~

~~CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 29, 2022~~

~~(in thousands, except share and per share data)~~

and the maturity date was extended to September 22, 2022. On July 29, 2022, in conjunction with the Fourth Amendment, the Company repaid $46,679 of short-term borrowings, repaying in full and retiring the term loan facility maturing on September 22, 2022. Additionally, the Fourth Amendment modified the consolidated fixed charge coverage covenant, reducing the requirement to maintain a consolidated fixed charge coverage ratio of at least 3.0 to 1.0 to at least 2.5 to 1.0 starting as of the end of the fiscal quarter ending March 30, 2023, and continuing for each fiscal quarter thereafter.

SOFR. Borrowings under the Credit Agreement now generally bear interest at a variable rate equal to: (i) ~~LIBOR,~~SOFR plus a credit spread adjustment of 0.10%, subject to a 1%0% floor, plus a specified margin based upon ~~the Company’s~~our consolidated debt to capitalization ratio as of the most recent determination date; or (ii) the base rate (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1%

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)

plus one-month ~~LIBOR)~~SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon ~~the Company’s~~our consolidated debt to capitalization ratio as of the most recent determination date. In addition, the Credit Agreement generally requires the Company to pay a facility fee equal to 0.125% to 0.25% of the total revolving commitment, depending on ~~its~~our consolidated debt to capitalization ratio, as defined in the Credit Agreement. However, pursuant to the First Amendment and the Second Amendment: (A) in respect of revolving loans, (1) the Company is charged a facility fee equal to 0.40% of the total revolving credit facility commitment and (2) the specified margin is 2.35% for LIBOR borrowings and 1.35% for ABR borrowings, which facility fee rate and specified margins will remain in effect until the end of the first fiscal quarter ending after the end of any period in which any portion of the term loan facility remains outstanding or the testing of any financial covenant in the Credit Agreement is suspended (the “specified period”); and (B) in respect of term loans, the specified margin is 2.75% for LIBOR borrowings and 1.75% for ABR borrowings, in each case, at all times.

The Credit Agreement contains various restrictions and covenants. Among other requirements, the Credit Agreement (a) limits the amount of priority debt (as defined in the Credit Agreement) held by the Company’s restricted subsidiaries to no more than 20% of the Company’s consolidated total capitalization (as defined in the Credit Agreement), (b) limits the Company’s permissible consolidated debt to capitalization ratio to a maximum of 0.55 to 1.0, (c) requires the Company to maintain a consolidated fixed charge coverage ratio of at least 2.5 to 1.0 as of the end of the fiscal quarter ending March 30, 2023 and each fiscal quarter thereafter, and (d) restricts the Company’s ability to incur additional indebtedness ~~pay dividends and other distributions (the restriction on dividends and other distributions does not apply to subsidiaries),~~ and make voluntary prepayments on or defeasance of the Company’s 4.02% Senior Notes due August 2025, 4.32% Senior Notes due February 2027, the notes or certain other convertible ~~securities, (e) requires~~securities. Beginning with the ~~Company’s consolidated EBITDA not to be less than or equal to (i) $10,000 as~~first quarter of ~~December 30, 2021 for the two consecutive~~ fiscal quarters then ending, (ii) $25,000 as of March 31, 2022 for the three consecutive fiscal quarters then ending, (iii) $50,000 as of June 30, 2022 for the four consecutive fiscal quarters then ending, (iv) $65,000 as of September 29, 2022 for the four consecutive fiscal quarters then ending, or (v) $70,000 as of December 29, 2022 for the four consecutive fiscal quarters then ending, (f) requires the Company’s consolidated liquidity not to be less than or equal to (i) $100,000 as of September 30, 2021, (ii) $100,000 as of December 30, 2021, (iii) $100,000 as of March 31, 2022, (iv) $100,000 as of June 30, 2022, or (v) $50,000 as of the end of any fiscal quarter thereafter until and including the fiscal quarter ending December 29, 2022; however, each such required minimum amount of consolidated liquidity would be reduced to $50,000 for each such testing date if the initial term loans are paid in full as of such date, and (g) prohibits2023, the Company from incurring or making capital expenditures, (i) during fiscal 2021 in excess of the sum of $40,000 plus certain adjustments, or (ii) during the Company’s 2022 fiscal year in excess of $50,000 plus certain adjustments.

~~Pursuant~~has returned to the Credit Agreement, the Company is required to apply net cash proceeds received from certain events, including certain asset disposition, casualty losses, condemnations, equity issuances, capital contributions, and the incurrence of certain debt, to prepay outstanding term loans. During the 39 weeks ended September 29, 2022, approximately $820 in asset sale proceeds were applied to the term loan balance. In addition, if, at any time during the specified period, the Company’s unrestricted cash on hand exceeds $75,000, the Company is required to prepay revolving loanscompliance with prior financial covenants under the Credit Agreement bythat were temporarily waived (specifically, the consolidated fixed charge coverage ratio), removing any limitations on the total amount of ~~such excess, without a corresponding reduction in the revolving commitments under~~quarterly dividends or share repurchases. During fiscal 2022 the Credit ~~Agreement.~~Agreement limited the total amount of quarterly dividend payments or share repurchases to no more than $1,550 per quarter.

In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries

~~Table of Contents~~

~~THE MARCUS CORPORATION~~

~~CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 29, 2022~~

~~(in thousands, except share and per share data)~~

have guaranteed the Company’s obligations under the Credit Agreement. The foregoing security interests, liens and guaranties will remain in effect until the Collateral Release Date (as defined in the Credit Agreement).

The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.

Note Purchase Agreements

At ~~September~~June 29, 2023 and December 29, 2022, ~~and December 30, 2021,~~ the Company’s $80,000 ~~and $90,000, respectively,~~ of senior notes consist of two Purchase Agreements maturing in 2025 through 2027, require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 4.32%.

Convertible Senior Notes

On September 17, 2020, the Company entered into a purchase agreement to issue and sell $100,050 aggregate principal amount of its 5.00% Convertible Senior Notes due 2025 (the “Convertible Notes.”) The Convertible Notes were issued pursuant to an indenture (the “Indenture”), dated September 22, 2020, between the Company and U.S. Bank National Association, as trustee.

The Convertible Notes bear interest from September 22, 2020 at a rate of 5.00% per year. Interest will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Convertible Notes may bear additional interest under specified circumstances relating to the Company’s failure to comply with its reporting obligations under the Indenture or if the Convertible Notes are not freely tradeable as required by the Indenture. The Convertible Notes will mature on September 15, 2025, unless earlier repurchased or converted. Prior to March 15, 2025, the Convertible Notes will be convertible at the option of the holders only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and per share data)

product of the last reported sale price of the Common Stock and the conversion rate on each such trading day; or (iii) upon the occurrence of specified corporate events. On or after March 15, 2025, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

Upon conversion, the Convertible Notes may be settled, at the Company’s election, in cash, shares of Common Stock or a combination thereof. The initial conversion rate was 90.8038 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $11.01 per share of Common Stock), representing an initial conversion premium of approximately 22.5% to the $8.99 last reported sale price of the Common Stock on The New York Stock Exchange on September 17, 2020. The conversion rate is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At ~~September~~June 29, ~~2022,~~2023, the applicable conversion rate is ~~91.0729~~91.9631 shares of Common Stock per $1,000 principal amount of the Convertible ~~Notes.~~Notes (equivalent to an applicable conversion price of approximately $10.87 per share of Common Stock). If the Company undergoes certain fundamental changes, holders of Convertible Notes may require the Company to repurchase for cash all or part of their Convertible Notes for a purchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a make-whole fundamental change occurs prior to the maturity date, the Company will, under certain circumstances, increase the conversion rate for holders who convert Convertible Notes in connection with such make-whole fundamental change. The Company may not redeem the Convertible Notes before maturity and no “sinking fund” is provided for the Convertible Notes. The Indenture includes covenants customary for securities similar to the Convertible Notes, sets forth certain events of default after which the Convertible Notes may be declared immediately due and payable and sets forth

~~Table of Contents~~

~~THE MARCUS CORPORATION~~

~~CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 29, 2022~~

~~(in thousands, except share and per share data)~~

certain types of bankruptcy or insolvency events of default involving the Company and certain of its subsidiaries after which the Convertible Notes become automatically due and payable.

~~During~~Since the Company’s fiscal 2021 second ~~third and fourth quarters, and~~quarter through the Company’s fiscal ~~2022 first, second,~~2023 third ~~and fourth quarters,~~quarter, the Company’s Convertible Notes were (are) eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. The Company has the ability to settle the conversion in Company stock. As such, the Convertible Notes will continue to be classified as long-term. Future convertibility and resulting balance sheet classification of this liability will be monitored at each quarterly reporting date and will be analyzed dependent upon market prices of the Company’s Common Stock during the prescribed measurement period. No Convertible Notes have been converted to date and the Company does not expect any to be converted within the next 12 months.

~~Derivatives~~

~~The Company utilizes derivatives principally~~In connection with the pricing of the Convertible Notes on September 17, 2020, and in connection with the exercise by the Initial Purchasers (as defined in the Convertible Notes purchase agreement) of their option to manage market risks and reduce its exposure resulting from fluctuations in interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategies for undertaking various hedge transactions.

~~The~~purchase additional Convertible Notes on September 18, 2020, the Company entered into ~~two interest rate swap agreements on March 1, 2018 covering $50,000~~privately negotiated Capped Call Transactions (the “Capped Call Transactions”) with certain of ~~floating rate debt.~~the Initial Purchasers and/or their respective affiliates and/or other financial institutions (the “Capped Call Counterparties”). The ~~first agreement had a notional~~Capped Call Transactions are expected generally to reduce potential dilution of the Company’s common stock upon any conversion of the Convertible Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of ~~$25,000, expired March 1, 2021~~such converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the conversion price of the Convertible Notes and ~~required~~is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, there would nevertheless be dilution to the extent that such market price exceeds the cap price of the Capped Call Transactions. The cap price of the Capped Call Transactions was initially $17.98 per share (in no event shall the cap price be less than the strike price of $11.0128), which represents a premium of 100% over the last reported sale price of the Common Stock of $8.99 per share on The New York Stock Exchange on September 17, 2020. Under the terms of the Capped Call Transactions, the cap price is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At June 29, 2023, the adjusted cap price is approximately $17.75 per share. The Capped Call Transactions are separate transactions entered into by the Company ~~to pay interest at a defined rate~~with the Capped Call Counterparties, are not part

Table of ~~2.559% while receiving interest at a defined variable rate of one-month LIBOR. The second agreement has a notional amount of $25,000, expires March 1,~~Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 29, 2023

(in thousands, except share and requires the Company to pay interest at a defined rate of 2.687% while receiving interest at a defined variable rate of one-month LIBOR (2.563% at September 29, 2022). The Company’s interest rate swap agreement is considered effective and qualifies as a cash flow hedge. The Company assesses, both at the inception of each hedge and on an on-going basis, whether the derivatives that are used in its hedging transactions are highly effective in offsetting changes in cash flows per share data)

of the ~~hedged items. As of September 29, 2022, the remaining interest rate swap was considered highly effective. The fair value~~terms of the ~~interest rate swap on September 29, 2022 was an asset~~Convertible Notes and will not change the rights of ~~$130, which is included in other current assets in the consolidated balance sheet. The fair value~~holders of the ~~interest rate swap on December 30, 2021, was a liability of $689, which was included in other long-term obligations in~~Convertible Notes under the ~~consolidated balance sheet. The Company does not expect~~Convertible Notes and the ~~interest rate swap to have a material effect on earnings over its remaining term.~~Indenture.

5.3. Leases

The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to accounting guidance ASU No. 2016-02, Leases (Topic 842). The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.

The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

Total lease cost consists of the following:


		13 Weeks Ended				26 Weeks Ended
Lease Cost	Classification	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Finance lease costs:
Amortization of finance lease assets	Depreciation and amortization	$	688	$	696	$	1,379	$	1,401
Interest on lease liabilities	Interest expense	192		216		390		437
		$	880	$	912	$	1,769	$	1,838
Operating lease costs:
Operating lease costs	Rent expense	$	6,033	$	6,364	$	12,077	$	12,741
Variable lease cost	Rent expense	527		178		943		15
Short-term lease cost	Rent expense	34		36		67		72
		$	6,594	$	6,578	$	13,087	$	12,828

Additional information related to leases is as follows:


	13 Weeks Ended				26 Weeks Ended
Other Information	June 29, 2023		June 30, 2022		June 29, 2023		June 30, 2022

Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases	$	645	$	752	$	1,201	$	1,336
Operating cash flows from finance leases	192		216		390		437
Operating cash flows from operating leases	6,429		7,012		12,859		$	14,136

Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities	136		116		136		188
Operating lease liabilities	—		—		—		183

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 3926 WEEKS ENDED ~~SEPTEMBER~~JUNE 29, ~~2022~~2023

(in thousands, except share and per share data)

~~Total lease cost consists of the following:~~

13 Weeks Ended 39 Weeks Ended
Lease Cost Classification September 29, 2022 September 30, 2021 September 29, 2022 September 30, 2021
Finance lease costs:
Amortization of finance lease assets Depreciation and amortization $ 692 $ 677 $ 2,093 $ 2,057
Interest on lease liabilities Interest expense 210 234 647 724
$ 902 $ 911 $ 2,740 $ 2,781
Operating lease costs:
Operating lease costs Rent expense $ 6,364 $ 6,365 $ 19,105 $ 19,151
Variable lease cost Rent expense 273 144 288 (29)
Short-term lease cost Rent expense 35 35 107 107
$ 6,672 $ 6,544 $ 19,500 $ 19,229

~~Additional information related to leases is as follows:~~

13 Weeks Ended 39 Weeks Ended
Other Information September 29, 2022 September 30, 2021 September 29, 2022 September 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases $ 711 $ 736 $ 2,047 $ 2,065
Operating cash flows from finance leases 210 234 647 724
Operating cash flows from operating leases 6,917 8,253 21,053 $ 23,545
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities 119 — 307 —
Operating lease liabilities 92 287 275 1,862

September 29, 2022 December 30, 2021
Finance leases:
Property and equipment – gross $ 75,282 $ 75,124
Accumulated depreciation and amortization (60,147) (58,197)
Property and equipment - net $ 15,135 $ 16,927

~~Table of Contents~~

~~THE MARCUS CORPORATION~~

~~CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 29, 2022~~

~~(in thousands, except share and per share data)~~


	June 29, 2023		December 29, 2022

Finance leases:
Property and equipment – gross	$	29,997	$	29,885
Accumulated depreciation and amortization	(16,687)		(15,332)
Property and equipment - net	$	13,310	$	14,553

Remaining lease terms and discount rates are as follows:

Lease Term and Discount Rate

September 29, 2022

December 30, 2021

Lease Term and Discount Rate

June 29, 2023

December 29, 2022

Weighted-average remaining lease terms:

Finance leases

8 years

Finance leases

7 years

Operating leases

13 years

Operating leases

12 years

Weighted-average discount rates:

Finance leases

4.59

4.58

Finance leases

4.59

Operating leases

4.51

4.48

Operating leases

4.51

Deferred rent payments of approximately ~~$1,076~~$753 for the Company’s operating leases have been included in the total operating lease obligations as of ~~September~~June 29, ~~2022,~~2023, of which approximately ~~$661~~$550 is included in long-term operating lease obligations.

6.4. Income Taxes

The Company’s effective income tax rate for the 13 and 3926 weeks ended ~~September~~June 29, ~~2022~~2023 was ~~31.3%~~23.3% and ~~9.8%~~24.0%, respectively, and was ~~7.9%~~34.7% and ~~27.6%~~23.1% for the 13 and 3926 weeks ended ~~September~~June 30, ~~2021,~~2022, respectively. The effective tax rate for the 3913 weeks ended ~~September 29,~~June 30, 2022 includes discrete tax expense related to various ~~matters including an increase in valuation allowances on certain state~~matters. During the 26 weeks ended June 30, 2022, the Company received $22,959 of income tax ~~net operating loss carryforwards. During the 39 weeks ended September 30, 2021, the Company filed income tax refund claims of $24,151~~refunds related to its fiscal 2020 tax return, ~~of which $1,828 was received in fiscal 2021, and $22,323 was received during the 39 weeks ended September 29, 2022. An additional~~including $636 of interest ~~was received during the 39 weeks ended September 29, 2022 and~~which is included within income tax benefit in the consolidated statement of earnings (loss). ~~During the 39 weeks ended September 30, 2021, the Company received the remaining $5,900 of requested tax refunds from its fiscal 2019 tax return.~~

~~7. Joint Venture Transactions~~

During the 39 weeks ended September 30, 2021, the Company sold its interest in an equity investment without a readily determinable fair value for $4,150 and recorded a gain of $2,079, which is included in gain (loss) on disposition of property, equipment and other assets in the consolidated statement of earnings (loss).

8.5. Business Segment Information

The Company’s primary operations are reported in the following business segments: Theatres and Hotels/Resorts. Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues.

1412

Table of Contents

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 3926 WEEKS ENDED ~~SEPTEMBER~~JUNE 29, ~~2022~~2023

(in thousands, except share and per share data)

Following is a summary of business segment information for the 13 and 3926 weeks ended ~~September~~June 29, ~~2022~~2023 and ~~September~~June 30, ~~2021:~~2022:


13 Weeks Ended	13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total		13 Weeks Ended	Theatres	Hotels/ Resorts	Corporate Items	Total
September 29, 2022
June 29, 2023										June 29, 2023	Theatres	Hotels/ Resorts	Corporate Items	Total
Revenues	Revenues	$	101,258	$	82,300	$	92	$	183,650	Revenues
Operating income (loss)	Operating income (loss)	(723)		14,120		(4,448)		8,949		Operating income (loss)	19,811	6,105	(5,106)	20,810
Depreciation and amortization	Depreciation and amortization	11,632		4,733		87		16,452		Depreciation and amortization	11,317	4,588	89	15,994

13 Weeks Ended	13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total		13 Weeks Ended	Theatres	Hotels/ Resorts	Corporate Items	Total
September 30, 2021
June 30, 2022										June 30, 2022	Theatres	Hotels/ Resorts	Corporate Items	Total
Revenues	Revenues	$	79,996	$	65,803	$	63	$	145,862	Revenues
Operating income (loss)	Operating income (loss)	(2,604)		13,458		(4,581)		6,273		Operating income (loss)	16,430	6,817	(4,354)	18,893
Depreciation and amortization	Depreciation and amortization	12,636		5,018		76		17,730		Depreciation and amortization	11,863	4,801	88	16,752

39 Weeks Ended		Theatres		Hotels/ Resorts		Corporate Items		Total
September 29, 2022
Revenues		$	310,186	$	203,958	$	303	$	514,447
Operating income (loss)		7,687		17,963		(14,605)		11,045
Depreciation and amortization		35,686		14,484		265		50,435

39 Weeks Ended		Theatres		Hotels/ Resorts		Corporate Items		Total
September 30, 2021
Revenues		$	154,859	$	134,079	$	258	$	289,196
Operating income (loss)		(46,458)		5,511		(14,551)		(55,498)
Depreciation and amortization		38,807		15,192		204		54,203


26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 29, 2023
Revenues	$	233,226	$	125,877	$	180	$	359,283
Operating income (loss)	21,330		1,073		(10,581)		11,822
Depreciation and amortization	22,805		8,889		176		31,870

26 weeks ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	208,928	$	121,658	$	211	$	330,797
Operating income (loss)	8,410		3,843		(10,157)		2,096
Depreciation and amortization	24,054		9,751		178		33,983

1513

Table of Contents

THE MARCUS CORPORATION

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) and elsewhere in this Form 10-Q are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects of the COVID-19 pandemic, or future pandemics, may have on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the ~~duration of the COVID-19 pandemic and related government restrictions and the level of customer demand following the relaxation of such requirements; (3) the~~ availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division ~~(particularly following~~(including disruptions in the ~~COVID-19 pandemic, during which~~production of films due to events such as a strike by actors, writers or directors); (3) the ~~release dates for certain motion pictures have been postponed), as well as other~~effects of theatre industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our ~~markets, including but not limited to, those caused by the COVID-19 pandemic;~~markets; (5) the effects of adverse economic conditions ~~including but not limited to, those caused by the COVID-19 pandemic,~~ on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) ~~the effects on our occupancy and room rates caused by the COVID-19 pandemic and~~ the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in the United States, other incidents of violence in public venues such as hotels and movie theatres or ~~epidemics (such as the COVID-19 pandemic);~~epidemics; and (14) a disruption in our business and reputational and economic risks associated with civil securities claims brought by shareholders. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, ~~including developments related to the COVID-19 pandemic,~~ some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Our forward-looking statements are based upon our assumptions, which are based upon currently available information, including assumptions about our ability to manage difficulties associated with or related to the COVID-19 pandemic; the assumption that our theatre closures, hotel closures and restaurant closures are not expected to be permanent or to re-occur; the continued availability of our workforce; and the temporary and long-term effects of the COVID-19 pandemic on our business.information. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

RESULTS OF OPERATIONS

General

We report our consolidated and individual segment results of operations on a 52- or 53-week fiscal year ending on the last Thursday in December. Fiscal ~~2022~~2023 is a 52-week year beginning on December ~~31, 2021~~30, 2022 and ending on December ~~29, 2022.~~28, 2023. Fiscal ~~2021~~2022 was a 52-week year that began on ~~January 1,~~December 31, 2021 and ended on December ~~30, 2021.~~29, 2022.

We divide our fiscal year into three 13-week quarters and a final quarter consisting of 13 or 14 weeks. The ~~third~~second quarter of fiscal 2023 consisted of the 13-week period beginning on March 31, 2023 and ended on June 29, 2023. The second quarter of fiscal 2022 consisted of the 13-week period beginning ~~on July~~April 1, 2022 and ended on ~~September 29,~~June 30, 2022. The ~~third quarter~~first half of fiscal ~~2021~~2023 consisted of the ~~13-week~~26-week period beginning ~~July 2, 2021~~on December 30, 2022 and ended on ~~September 30, 2021.~~June 29, 2023. The first ~~three~~

~~Table of Contents~~

~~quarters~~half of fiscal 2022 consisted of the ~~39-week~~26-week period beginning on December 31, 2021 and ended on ~~September 29,~~June 30, 2022. ~~The first three quarters of fiscal 2021 consisted of the 39-week period beginning January 1, 2021 and ended on September 30, 2021.~~ Our primary operations are reported in the following two business segments: movie theatres and hotels and resorts. Within this MD&A, amounts for totals, subtotals, and variances may not recalculate exactly within tables due to rounding as they are calculated using the unrounded numbers.

Table of Contents

COVID-19 did not materially impact our results for the first quarter and first half of fiscal 2023. For discussion regarding the impact of COVID-19 and related economic conditions on our results for the year ended December ~~30, 2021,~~29, 2022, see “Part II-Item 7-Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our ~~2021~~2022 Annual Report. For ~~further~~ discussion regarding ~~the~~potential impacts of ~~COVID-19 and related economic conditions on our results for the first three quarters of fiscal 2022 and potential~~ future ~~impacts, see immediately below, and also~~pandemics refer to the discussion of our operational risks and financial risks found in “Part I-Item 1A-Risk Factors” in our ~~2021~~2022 Annual Report.

~~Impact of the COVID-19 Pandemic~~

The COVID-19 pandemic has had an unprecedented impact on the world and both of our business segments. As an operator of movie theatres, hotels and resorts, restaurants and bars, each of which consists of spaces where customers and guests gather in close proximity, our businesses were significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic, and our customers’ reactions or responses to such actions. The extent of these protective actions and their impact on our businesses has continued to dissipate during the first three quarters of fiscal 2022.

We began fiscal 2022 with all of our theatres open with normal operating days and hours. While still below pre-COVID-19 levels, attendance has continued to gradually improve as the number of vaccinated individuals increased, more films are released, and customers indicate increasing willingness to return to movie theatres. We remain optimistic that the theatre industry is in the process of rebounding and will continue to benefit from pent-up social demand now that a greater percentage of the population is vaccinated, the majority of state and local restrictions have been lifted and people seek togetherness with a return to normalcy.

We still expect a return to “normalcy” to be driven by an increase in the quality and quantity of new films released in theatres and the return of consumer comfort with public gatherings. The appearance of first, the Delta variant, and subsequently the Omicron variant, of the virus has resulted in changing government guidance on indoor activities in some communities, which impacted consumer comfort early in fiscal 2022. Industry customer surveys indicate that consumer comfort continues to increase, reaching a post-pandemic high comfort level in September 2022.

Total theatre division revenues, expressed as a percentage of fiscal 2019 pre-pandemic revenues, increased every quarter of fiscal 2021, increasing from 20% in the first quarter to 32% in the second quarter, 59% in the third quarter and 82% in the fourth quarter. We were very encouraged by the performance of multiple films released during the first three quarters of fiscal 2022, including ~~Top Gun: Maverick~~, ~~Doctor Strange in the Multiverse of Madness~~, ~~Jurassic World: Dominion, Minions: The Rise of Gru~~ ~~and~~ ~~The Batman~~. Total theatre division revenues in the first, second and third quarters of fiscal 2022, expressed as a percentage of fiscal 2019 revenues, were 69%, 80% and 74%, respectively. We believe the continued revenue shortfall compared to 2019 is driven primarily by a reduced quantity of films available for theatrical release during the fiscal 2022 periods.

We began fiscal 2022 with all eight of our company-owned and managed hotels open. All of our restaurants and bars in our hotels and resorts were open during the third quarter of fiscal 2022, operating in some cases with reduced operating hours. The majority of our hotels and restaurants are now generating revenues at or above pre-pandemic levels, while at certain hotels that primarily serve group business, revenues remain below pre-pandemic levels with improving occupancy and business travel activity increasing. The primary customer for hotels during the third quarter of fiscal 2022 continued to come from the leisure travel market. While business travel remained below pre-pandemic levels during the third quarter of fiscal 2022, we continued to see an increase in travel from this customer segment, particularly from small and mid-size group activity. As of the date of this report, our group room revenue bookings for fiscal 2022—commonly referred to in the hotels and resorts industry as “group pace”—is running behind where we would typically be at this same time in pre-pandemic years, but group pace has improved throughout the fiscal year and we have experienced increased booking activity in recent months for fiscal 2022 and 2023 and beyond. With companies implementing return to office plans, we remain optimistic that business travel will continue to increase during fiscal 2022 and beyond. Total hotel division revenues before cost reimbursements, expressed as a percentage of fiscal 2019 revenues before cost reimbursements, increased throughout fiscal 2021, including increases during fiscal 2021 from 53% in the first quarter to 63% in second quarter, 90%

~~Table of Contents~~

in the third quarter and 83% in the fourth quarter. Total hotel division revenues before cost reimbursements, expressed as a percentage of fiscal 2019 revenues before cost reimbursements, continued to increase during fiscal 2022 from 96% in the first quarter to 105% in the second quarter and 109% in the third quarter. The future economic environment will also have a significant impact on the pace of our return to “normal” hotel operations.

Maintaining and protecting a strong balance sheet has always been a core philosophy of The Marcus Corporation during our 87-year history, and, despite the COVID-19 pandemic, our financial position remains strong. As of September 29, 2022, we had a cash balance of approximately $10.5 million, $202.8 million of availability under our $225 million revolving credit facility and our debt-to-capitalization ratio was 0.33. With our strong liquidity position, combined with cash generated from operations and proceeds from the sale of surplus real estate (discussed below), we believe we are positioned to meet our obligations as they come due and continue to sustain our operations throughout fiscal 2022 and 2023, even if our properties continue to generate reduced revenues during these periods. In recognition of our significantly improved financial condition and improving operating results, during the third quarter of fiscal 2022 we elected to pay off our remaining short-term borrowings of $46.6 million early (initially borrowed at the onset of the pandemic) and reinstate our quarterly dividend.

During the first three quarters of fiscal 2022 we received a $23.0 million federal income tax refund (including $0.7 million of interest) related to our fiscal 2020 tax return, with the primary benefit derived from net operating loss carrybacks to prior years. We also received $4.3 million in state theatre grants during the first three quarters of fiscal 2022 that were awarded and accrued during the fourth quarter of fiscal 2021. Both the receipt of the income tax refund and grant funds contributed to our current strong liquidity position.

We continue to pursue sales of surplus real estate and other non-core real estate to further enhance our liquidity. During the first three quarters of fiscal 2022, we sold three land parcels, generating net proceeds of approximately $4.9 million. We do not expect to receive additional sales proceeds from real estate sales during the remainder of fiscal 2022, and we may receive additional sales proceeds of $5 - $10 million during the first half of fiscal 2023, depending upon demand for the real estate in question.

We cannot assure that the impact of the COVID-19 pandemic will not continue to have a material adverse effect on both our theatre and hotels and resorts businesses, results of operations, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness.

Overall Results

The following table sets forth revenues, operating income, ~~(loss),~~ other income (expense), net earnings (loss) and net earnings (loss) per diluted common share for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 (in millions, except for per share and variance percentage data):

Third Quarter First Three Quarters
Variance Variance
F2022 F2021 Amt. Pct. F2022 F2021 Amt. Pct.
Revenues $ 183.7 $ 145.9 $ 37.8 25.9 % $ 514.4 $ 289.2 $ 225.3 77.9 %
Operating income (loss) 8.9 6.3 2.7 42.7 % 11.0 (55.5) 66.5 119.8 %
Other income (expense) (4.2) (4.4) 0.2 4.6 % (14.0) (13.2) (0.8) (6.1) %
Net earnings (loss) attributable to The Marcus Corp. $ 3.3 $ 1.8 $ 1.5 87.0 % $ (2.7) $ (49.7) $ 47.1 94.8 %
Net earnings (loss) per common share - diluted: $ 0.10 $ 0.06 $ 0.04 66.7 % $ (0.09) $ (1.66) $ 1.57 94.6 %


	Second Quarter								First Half
					Variance								Variance
	F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Revenues	$	207.0	$	198.6	$	8.5	4.3	%	$	359.3	$	330.8	$	28.5	8.6	%
Operating income	20.8		18.9		1.9		10.1	%	11.8		2.1		9.7		464.0	%
Other income (expense)	(3.2)		(5.2)		1.9		37.3	%	(6.6)		(9.8)		3.3		33.2	%
Net earnings (loss)	$	13.5	$	9.0	$	4.5	50.3	%	$	4.0	$	(5.9)	$	9.9	167.3	%
Net earnings (loss) per common share - diluted	$	0.35	$	0.24	$	0.11	45.8	%	$	0.13	$	(0.19)	$	0.32	168.4	%

Revenues increased and operating income, ~~(loss),~~ net earnings (loss) ~~attributable to The Marcus Corporation~~ and net earnings (loss) per diluted common share improved ~~significantly~~ during the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 compared to the second quarter and first half of fiscal ~~2021 periods.~~2022. Increased revenues and operating income from both our theatre division and hotels and resorts division contributed to the improvement during the ~~third~~second quarter and first ~~three quarters~~half of fiscal 2023 compared to the second quarter and first half of fiscal 2022. The first half of fiscal 2022 ~~compared~~was negatively impacted due to the ~~third quarter and first three quarters of fiscal 2021. During portions of fiscal 2021, some of our theatres were closed,~~fact that releases of new films were limited and travel was ~~significantly~~ reduced due to the ~~impact~~lingering impacts of the COVID-19 ~~pandemic.~~

~~Table of Contents~~

~~Our operating income (loss) during the third quarter~~pandemic and first three quarters of fiscal 2021 was favorably impacted by state government grants of approximately $2.0 million and $3.3 million, respectively, or approximately $0.05 and $0.08 per diluted common share, respectively. Our operating losssubsequent variants, particularly during the first ~~three quarters~~quarter of fiscal ~~2021 was negatively impacted by impairment charges of $3.7 million, or approximately $0.09 per diluted common share, primarily related to surplus real estate that was held for sale.~~2022.

Net earnings (loss) ~~attributable to The Marcus Corporation~~ during the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 was favorably impacted by decreased interest expense compared to the ~~fiscal 2021 periods, partially offset by investment losses during the fiscal 2022 periods compared to investment gains in the fiscal 2021 periods,~~second quarter and ~~lower gains on disposition of property, equipment and other assets during the~~ first ~~three quarters of fiscal 2022 as compared to the first three quarters of fiscal 2021.~~

~~Investment losses during the third quarter~~half of fiscal 2022 and investment income during the second quarter and first half of fiscal ~~2021 were insignificant.~~ 2023 compared to investment losses in the second quarter and first half of fiscal 2022.

We recognized investment ~~losses~~income of ~~$0.8~~$0.4 million and $0.6 million during the second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023, respectively, compared to investment ~~income~~losses of ~~$0.2~~$0.5 million and $0.7 million for the respective fiscal ~~2021 period.~~2022 periods. Variations in investment income were due to changes in the value of marketable securities.

Our interest expense totaled ~~$3.7~~$3.1 million and ~~$11.8~~$6.1 million for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022,~~2023, respectively, compared to ~~$4.6~~$4.1 million and ~~$14.4~~$8.2 million for the respective fiscal ~~2021~~2022 periods. The decrease in interest expense ~~for both periods~~ in fiscal ~~2022~~2023 was primarily due to decreased borrowings and a decrease in non-cash amortization of deferred financing costs. Changes in our borrowing levels due to variations in our operating results, capital expenditures, acquisition opportunities (or the lack thereof) and asset sale proceeds, among other items, may impact, either favorably or unfavorably, our actual reported interest expense in future periods, as may changes in short-term interest rates.

We reported net losses on disposition of property, equipment and other assets of $0.1 million during the third quarter of fiscal 2022, compared to net gains on disposition of property, equipment and other assets of $0.9 million during the third quarter of fiscal 2021. We reported net gains on disposition of property, equipment and other assets of $0.3 million during the first three quarters of fiscal 2022, compared to net gains on disposition of property, equipment and other assets of $2.9 million during the first three quarters of fiscal 2021. The net gain on disposition of property, equipment and other assets during the first three quarters of fiscal 2022 was due primarily to the sale of surplus land. The net gain on disposition of property, equipment and other assets during the first three quarters of fiscal 2021 included the sale of an equity investment in a joint venture. The timing of periodic sales and disposals of our property, equipment and other assets varies from quarter to quarter, resulting in variations in our reported gains or losses on disposition of property, equipment and other assets. We anticipate additional disposition gains or losses from periodic sales of property, equipment and other assets during fiscal 2022 and beyond.

We reported income tax expense for the ~~third~~second quarter of fiscal ~~2022~~2023 of ~~$1.5~~$4.1 million compared to an income tax expense of ~~$0.2~~$4.8 million during the ~~third~~second quarter of fiscal ~~2021.~~2022. We reported an income tax ~~benefit~~expense for the first ~~three quarters~~half of fiscal ~~2022~~2023 of ~~$0.3~~$1.3 million compared to an income tax benefit of ~~$18.9~~$1.8 million during the first ~~three quarters~~half of fiscal 2021. The income tax benefit during the fiscal 2021 periods was primarily the result of the significant losses before income taxes incurred as a result of the reduction in our operating performance due to the impact of the COVID-19 pandemic as described above.2022. Our fiscal ~~2022~~2023 first ~~three quarters~~half effective income tax rate was ~~9.8%, and was impacted by an increase in valuation allowances on certain state income tax net operating loss carryforwards.~~24.0%. Our fiscal ~~2021~~2022 first ~~three quarters~~half effective income tax rate was ~~27.6%~~23.1%. We anticipate that our effective income tax rate for ~~the fourth quarter of~~ fiscal ~~2022~~2023 may be in the 24-28% range, excluding any potential changes in federal or state income tax rates, valuation allowance adjustments or other one-time tax benefits. Our actual fiscal ~~2022~~2023 effective income tax rate may be different from our estimated quarterly rates depending upon actual facts and circumstances.

As of September 29, 2022, we had approximately $11.4 million of deferred tax assets, net of valuation allowances, related to state net operating loss (NOL) carryforwards that can be used to offset taxable income in future periods and reduce our income taxes payable in those future periods. Many of these state NOL carryforwards will expire if they are not used within certain periods. At this time, we consider it more likely than not that we will have sufficient taxable income in the future that will allow us to realize these deferred tax assets. However, it is possible that some or all of these state NOL carryforwards could ultimately expire unused. Therefore, unless we are able to generate sufficient taxable income in certain states, an additional valuation allowance to reduce our state deferred tax assets may be required, which would increase income tax expense in the period the allowance is recorded. In future periods, sufficient positive evidence of current and anticipated future taxable earnings in these states may become available to allow us to reach a conclusion that all or a portion of the valuation allowance is no longer needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and decrease income tax expense for the period the release is recorded.

1915

Table of Contents

Theatres

The following table sets forth revenues, operating income ~~(loss)~~ and operating margin for our theatre division for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 (in millions, except for variance percentage and operating margin):

Third Quarter First Three Quarters
Variance Variance
F2022 F2021 Amt. Pct. F2022 F2021 Amt. Pct.
Revenues $ 101.3 $ 80.0 $ 21.3 26.6 % $ 310.2 $ 154.9 $ 155.3 100.3 %
Operating income (loss) (0.7) (2.6) 1.9 73.1 % 7.7 (46.5) 54.1 116.3 %
Operating margin
(% of revenues) (0.7) % (3.3) % 2.5 % (30.0) %


	Second Quarter										First Half
							Variance										Variance
	F2023			F2022			Amt.		Pct.		F2023			F2022			Amt.		Pct.
Revenues	$	136.9		$	129.4		$	7.4	5.7	%	$	233.2		$	208.9		$	24.3	11.6	%
Operating income	19.8			16.4			3.4		20.6	%	21.3			8.4			12.9		153.6	%
Operating margin (% of revenues)	14.5		%	12.7		%					9.1		%	4.0		%

Our theatre division revenues and operating income increased ~~significantly~~ during the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023, with ~~all of our theatres open and~~ an increase in the number of new films released by movie studios resulting in higher attendance compared to the ~~fiscal 2021 periods during portions of which a significant number of our theatres were temporarily closed and releases of new films were limited. We began the~~ first ~~quarter~~half of fiscal 2021 with approximately 52% of our theatres open. As state and local restrictions were eased in several of our markets and several new films were released by movie studios, we gradually reopened theatres, ending the fiscal 2021 first, second and third quarters with approximately 74%, 95% and 97% of our theatres open, respectively. The majority of our reopened theatres operated with reduced2022. Our operating ~~days (Fridays, Saturdays, Sundays and Tuesdays) and reduced operating hours~~income during the ~~fiscal 2021 first~~second quarter and by the end of May 2021 we had returned the vast majority of our theatres to normal operating days (seven days per week) and operating hours. Our theatres were open with normal operating days and hours at all of our theatres throughout the first ~~three quarters~~half of fiscal ~~2022.~~

~~Although~~2023 significantly improved compared to the ~~prior year, our operating loss during the third~~second quarter and ~~operating income during the~~ first ~~three quarters~~half of fiscal 2022 ~~were negatively impacted by increased film costs (discussed below) and increased labor and supply costs~~ as a result of ~~the current~~higher overall revenues and greater labor shortage and inflationary environment. Our operating loss during the third quarter and operating income during the first three quarters of fiscal 2022 were favorably impacted by inflationary price increases taken later in the second quarter of fiscal 2022 in response to the increased labor and supply costs. Our operating loss during the first three quarters of fiscal 2021 was negatively impacted by impairment charges of $3.7 million primarily related to surplus real estate that was held for sale, and would have been even larger if not for a nonrecurring state government grant of approximately $1.3 million that favorably impacted our theatre division operating loss.productivity.

The following table provides a further breakdown of the components of revenues for the theatre division for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 (in millions, except for variance percentage):

Third Quarter First Three Quarters
Variance Variance
F2022 F2021 Amt. Pct. F2022 F2021 Amt. Pct.
Admission revenues $ 49.4 $ 38.3 $ 11.1 29.0 % $ 150.9 $ 73.9 $ 77.0 104.3 %
Concession revenues 44.7 36.0 8.7 24.2 % 138.3 68.9 69.4 100.7 %
Other revenues 7.1 5.8 1.3 22.4 % 20.9 12.0 8.9 74.2 %
101.3 80.0 21.3 26.6 % 310.2 154.8 155.4 100.4 %
Cost reimbursements — — — — % — 0.1 (0.1) (100.0) %
Total revenues $ 101.3 $ 80.0 $ 21.3 26.6 % $ 310.2 $ 154.9 $ 155.3 100.3 %

As described above, revenues were significantly reduced during the third quarter and first three quarters of fiscal 2021 due to a limited number of films and the temporary closures and reduced operating days and hours at our theatres in response to the COVID-19 pandemic. As a result, we believe it is also beneficial to compare our revenues to pre-pandemic levels. The

~~Table of Contents~~

following table compares the components of revenues for the theatre division for the third quarter and first three quarters of fiscal 2022 to the third quarter and first three quarters of fiscal 2019 (in millions, except for variance percentage):

Third Quarter First Three Quarters
Variance Variance
F2022 F2019 Amt. Pct. F2022 F2019 Amt. Pct.
Admission revenues(1)
$ 49.4 $ 69.8 $ (20.3) (29.1) % $ 150.9 $ 211.8 $ (60.8) (28.7) %
Concession revenues 44.7 57.1 (12.3) (21.6) % 138.3 172.1 (33.8) (19.6) %
Other revenues 7.1 9.8 (2.7) (27.2) % 20.9 29.5 (8.6) (29.1) %
101.3 136.6 (35.3) (25.9) % 310.2 413.4 (103.2) (25.0) %
Cost reimbursements — 0.2 (0.2) (100.0) % — 0.6 (0.6) (100.0) %
Total revenues $ 101.3 $ 136.8 $ (35.5) (26.0) % $ 310.2 $ 414.1 $ (103.9) (25.1) %

~~(1)~~We acquired Movie Tavern theatres on February 1, 2019. Admission revenues for the first three quarters of fiscal 2022 decreased 30.2% on a pro forma basis for the acquisition as of the first day of fiscal 2019.


	Second Quarter								First Half
					Variance								Variance
	F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Admission revenues	$	69.0	$	63.1	$	5.9	9.4	%	$	116.6	$	101.5	$	15.1	14.9	%
Concession revenues	59.7		58.1		1.6		2.7	%	102.1		93.6		8.5		9.0	%
Other revenues	8.2		8.2		—		(0.6)	%	14.5		13.8		0.7		5.1	%
Total revenues	136.9		129.4		7.4		5.7	%	233.2		208.9		24.3		11.6	%

According to data received from Comscore (a national box office reporting service for the theatre industry) and compiled by us to evaluate our fiscal ~~2022 third~~2023 second quarter and first ~~three quarters~~half results, U.S. box office receipts ~~decreased 32.1%~~increased 13.6% during our fiscal ~~2022 third~~2023 second quarter and ~~33.5%~~18.3% during our fiscal ~~2022~~2023 first ~~three quarters~~half compared to the same comparable weeks in fiscal ~~2019,~~2022, indicating that our ~~decrease~~increase in admission revenues for comparable theatres (excluding theatres closed during the ~~third~~past year) during the second quarter and first half of fiscal 2023 of 9.7% and 15.2% underperformed the industry by 3.9 and 3.1 percentage points, respectively. We believe our underperformance is attributable to the more significant impact of lingering variants of COVID-19 in other regions of the country than in our primarily Midwestern markets during the first half of fiscal 2022, representing a higher opportunity for growth in 2023 nationally than in our markets. We also believe our underperformance during the second quarter of fiscal ~~2022 of 29.1% outperformed the industry by 3.0 percentage points. Our pro forma decrease~~2023 is attributable to an unfavorable film mix that was more appealing to audiences in ~~admission revenues during the first three quarters of fiscal 2022 of 30.2% outperformed the industry by 3.3 percentage points. Based upon this metric, we believe we were once again one~~other parts of the ~~top performing theatre circuits during fiscal 2022 compared~~U.S. outside of our Midwestern markets, as well as a dry May and June with few rainy days in the Midwest, resulting in customers preferring to enjoy early summer weather and outdoor activities over going to the ~~top 10 circuits in the U.S.~~ movies.

Additional data received and compiled by us from Comscore indicates our admission revenues during the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 represented approximately 3.1% and 3.2%, respectively, of the total admission revenues in the U.S. during the periods (commonly referred to as market share in our industry). This represents ~~an increase~~a decrease over our market share for comparable theatres of approximately 3.2% and 3.3% during the second quarter and first half of fiscal 2022, respectively, which we believe is also attributable to lingering COVID-19 variants more significantly impacting other regions of the country during the comparable periods in fiscal 2022. Our reported market share ~~of approximately 3.0% and 3.1%~~ during the ~~third quarter and first three quarters of~~comparable fiscal 2019 ~~respectively,~~periods prior to the ~~pandemic.~~pandemic, was approximately 3.1%. Our goal is to continue our past long-term pattern of outperforming the industry, but ~~with the majority of our renovations now completed,~~ our ability to do so in any given quarter will likely be partially dependent upon film mix, weather and the competitive landscape in our markets.

Total theatre attendance ~~increased significantly~~for our comparable theatres decreased 3.8% during the ~~third~~second quarter ~~and first three quarters~~of fiscal 2023 compared to the second quarter of fiscal 2022, ~~compared~~which was primarily attributable to lower performances from the ~~third quarter and first~~top three ~~quarters of fiscal 2021, when a significant portion of our theatres were temporarily closed and~~films this year versus the ~~number of new~~top three films ~~was more limited. Total theatre attendance increased 28.0% and 97.8%~~last year during the ~~third~~second quarter ~~and first three quarters~~(led by Top Gun: Maverick), partially offset by the favorable

Table of ~~fiscal 2022, respectively, compared to the third quarter and first three quarters~~Contents

impact of ~~fiscal 2021, resulting in increases in both admission revenues and concession revenues. Conversely, a decrease~~an increase in the number of ~~new~~wide-release films ~~and lingering customer concerns regarding visiting indoor businesses negatively impacted attendance~~(films showed in over approximately 1,500 theatres in the U.S.). During the second quarter of fiscal 2023 there were 29 wide-release films compared to 19 wide-release films during the ~~third~~second quarter ~~and first three quarters~~ of fiscal ~~2022 as~~2022.

Total theatre attendance for our comparable theatres increased 3.0% during the first half of fiscal 2023 compared to the ~~same periods~~prior year period, resulting primarily from an increase in the number of wide-release films. During the first half of fiscal ~~2019.~~2023 there were 52 wide-release films compared to 38 wide-release films during the first half of fiscal 2022.

Our highest grossing films during the fiscal ~~2022 third~~2023 second quarter included ~~Minions:~~ The ~~Rise of Gru~~Super Mario Bros. Movie, ~~Thor: Love and Thunder~~, ~~Top Gun: Maverick, Where~~Guardians of the ~~Crawdads Sing~~Galaxy Vol. 3, Spider-Man Across the Spider-Verse, The Little Mermaid and ~~Nope~~Fast X. All of these five films debuted with an exclusive theatrical run prior to release on streaming services. This compares with three of the top five films in the third quarter of fiscal 2021 that were released “day-and-date” on streaming services. We believe such “day-and-date” releases negatively impact theatrical revenues, particularly in week two and beyond of a films’ release. We also believe “day-and-date” releases increase piracy, further impacting potential revenues. We believe our theatre circuit outperformed its competition on three of our top five revenue producing films during the third quarter of fiscal 2022. In addition, we believe our overall admission revenue outperformed the industry due in part to the fact that we believe our theatre circuit outperformed its competition on the next tier of films. Due to the impact of three particularly strong blockbusters released or playing during the third quarter of fiscal 2022 (~~Minions: The Rise of Gru~~, ~~Thor: Love and Thunder~~ ~~and~~ ~~Top Gun: Maverick), the film slate during the third quarter of fiscal 2022 was weighted more towards our top movies compared to the third quarter of fiscal 2021 and fiscal 2019, as evidenced by the fact that our~~Our top five films during our fiscal ~~2022 third~~2023 second quarter accounted for ~~62%~~64% of our total box office results, compared to ~~49% and 58%~~68% for the top five films during the ~~third~~second quarter of fiscal ~~2021 and fiscal 2019 (prior to the pandemic), respectively,~~2022, both expressed as a percentage of the total admission revenues for the period. ~~An increased reliance on just a few~~A decreased concentration of blockbuster films during a given quarter often has the effect of ~~increasing~~lowering our film rental costs during the period, as generally the better a particular film performs, the greater the film rental cost tends to be as a percentage of box office receipts. ~~As a result~~While the second quarter of ~~a more~~fiscal 2023 was slightly less concentrated ~~film slate~~on blockbuster films compared to the second quarter of fiscal 2022, our overall film rental cost ~~increased significantly during the third quarter~~as a percentage of ~~fiscal 2022~~admission revenues remained flat compared to the ~~same period in the~~ prior year.

~~Table of Contents~~

Our average ticket price increased ~~0.8%~~14.2% and 12.0% during the ~~third~~second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, ~~compared to the third quarter of fiscal 2021~~respectively, and ~~increased by 9.3% compared to the third quarter of fiscal 2019. The increase in our average ticket price during the third quarter of fiscal 2022 as compared to the third quarter of fiscal 2021~~ was favorably impacted by inflationary price increases ~~taken during~~that we implemented in the second quarter of fiscal 2022 and in the first quarter of fiscal 2023 in response to increases in labor and supply costs, and by a higher percentage of 3D ticket sales. During the last week of the first quarter of fiscal 2023, we implemented several pricing changes to our Value Tuesday promotion across our theatre circuit, which ~~was partially offset by $3.00 promotional ticket pricing on National Cinema Day~~has historically offered $5 admission and ~~a lower proportion~~free complementary-size popcorn to our loyalty program members. Our new Value Tuesday promotion features $6 admission for members of our free Magical Movie Rewards (MMR) loyalty program and $7 admission ~~revenues from evening showings and premium large format screens due to the mix of films. Our~~for non-MMR customers. The overall increase in average ticket price ~~increased 3.2% during the first three quarters~~favorably impacted our admission revenues of ~~fiscal 2022 compared to the first three quarters of fiscal 2021~~our comparable theatres by $8.5 million and ~~increased by 11.7% compared to the first three quarters of fiscal 2019. In addition to inflationary price increases taken~~$12.4 million during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, a larger proportion of admission revenues from our premium large format screens (with a higher ticket price) contributed to the increase in our average ticket price during the first three quarters of fiscal 2022 compared to the first three quarters of fiscal 2021. During portions of the first three quarters of fiscal 2021, we also offered older “library” film product for only $5.00 per ticket when there was limited availability of new films resulting in a lower average ticket price in the same period in the prior year.respectively.

Our average concession revenues per person decreased by 2.6% during the third quarter of fiscal 2022 compared to the third quarter of fiscal 2021 and increased by 21.2% compared to the third quarter of fiscal 2019. The decrease in our average concession revenues per person during the third quarter of fiscal 2022 compared to the third quarter of fiscal 2021 was due in part to a mix of films that played more to family and child audiences, which we believe results in lower average concession purchases and lower purchase rates, and by promotional concession pricing on National Cinema Day. These impacts were partially offset by inflationary increases in concessions prices in response to increases in food and labor costs. Our average concession revenues per person increased by ~~1.6%~~7.3% and 6.3% during the second quarter and first ~~three quarters~~half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, compared to the first three quarters of fiscal 2021 and increased by 26.0% compared to the first three quarters of fiscal 2019. As customers have returned to “normal” activities such as going to the movie theatre, they have demonstrated a propensity to spend at a higher rate than before the pandemic closures. We also believe a portion of the increase in our average concession revenues per person during the first three quarters of fiscal 2022 may be attributed to shorter lines at our concession standsrespectively, due to reduced attendance (during periods of high attendance, some customers do not purchase concessions because the line is too long). A portion of the increase in our average concession revenues per person is attributable to inflationary increases in concessions prices in response to increases in food and labor ~~costs.~~costs and due to the net positive impact of changes to our Value Tuesday promotion, which replaced free complementary-size popcorn with a 20% discount on all concessions, food and non-alcoholic beverages for MMR members. We also believe average concession revenues per person was positively impacted by a new food and beverage menu introduced in the fourth quarter of fiscal 2022. Finally, we believe that an increased percentage of customers buying their concessions in advance using our website, kiosk or our mobile app likely contributed to higher average concession revenues per person, as our experience has shown that customers are more likely to purchase more items when they order and pay electronically. ~~We expect to continue to report increased~~The increase in average concession revenues per person ~~in future periods~~favorably impacted our concession revenues of our comparable theatres by $3.9 million and $6.0 million during the second quarter and first half of fiscal 2023 compared to ~~pre-pandemic periods, but whether our customers will continue to spend at these current significantly higher levels in future periods is currently unknown.~~the second quarter and first half of fiscal 2022, respectively.

Other revenues during the second quarter of fiscal 2023 were consistent with the second quarter of fiscal 2022. Other revenues increased by ~~approximately $1.3 million during the third quarter of fiscal 2022 compared to the third quarter of fiscal 2021. Other revenues increased by approximately $8.9~~$0.7 million during the first ~~three quarters~~half of fiscal ~~2022~~2023 compared to the first ~~three quarters~~half of fiscal ~~2021.~~2022. The ~~increases were~~increase was primarily due to the impact of increased attendance on internet surcharge ticketing fees and preshow and in-app advertising ~~income.~~revenue.

Several films have performed well in the early weeks of our fiscal ~~2022 fourth~~2023 third quarter, including ~~Smile, Halloween Ends, Black Adam~~Indiana Jones & The Dial of Destiny, Mission: Impossible - Dead Reckoning Part One, Sound of Freedom, Barbie, andOppenheimer. ~~Ticket~~In fact, the last two films recently combined to ~~Paradise. Several~~produce the fourth highest box office weekend of all time. While the quantity of films available for theatrical exhibition remains below pre-pandemic levels, we expect to continue to see increases in the quantity of available films in 2023 compared to the prior year. Although it is possible that ~~were previously~~schedule changes may occur, new films scheduled ~~for release in~~to be released during the remainder of fiscal ~~2022 have shifted release dates into fiscal~~ 2023 due to production delays resulting from supply chain disruptions and a post-production backlog. We expect the lack of a significant number of blockbuster films, particularly during the first quarter of fiscal 2023, to negatively impact our operating results in the near-term, before the pace of new film releases is expected to increase once again. The current film product release schedule for the remainder of fiscal 2022 includes several new films that have potential to perform very well ~~including~~include ~~Black Panther: Wakanda Forever, Strange World, Devotion,~~Gran Turismo, Teenage Mutant Ninja Turtles: Mutant Mayhem, Blue Beetle, Strays, The ~~Fabelmans, Avatar:~~Meg 2: The ~~Way~~Trench, The Equalizer 3, The Nun II, The Expendables 4, Paw Patrol: The Mighty Movie, Killers of ~~Water, Puss in Boots:~~the Flower Moon, Dune: Part Two, Trolls Band Together, Hunger Games: The ~~Last~~Ballad of Songbirds and Snakes, Wish, Napoleon, Wonka, The Color Purpleand ~~Babylon.~~ Aquaman and the Lost Kingdom~~We believe that with consumer comfort now at post-pandemic highs, and assuming that concerns over any new variants~~.

Table of ~~COVID-19 do not result in significant new restrictions, demand for out-of-home entertainment will continue to remain strong.~~Contents

Revenues for the theatre business and the motion picture industry in general are heavily dependent on the number of films produced by studios and the general audience appeal of available films, together with studio marketing, advertising and support campaigns and the maintenance of appropriate “windows” between the date a film is released in theatres and the date a motion picture is released to other channels, including premium video-on-demand (“PVOD”), video on-demand (“VOD”), streaming services and DVD. These are factors over which we have no control. We currently believe that “day-and-date” film release experiments such as those tested by Warner Brothers and Disney during 2021 will not become the normal plan of distribution. Warner Brothers has indicated that it is returning to an exclusive 45-day theatrical window with a significant number of its films during fiscal 2022 and an increasing number of wide theatrical releases in 2023 and

~~Table of Contents~~

2024. Disney announced in early 2022 that they will retain flexibility for future film distribution, particularly for family films, but has released several films exclusively to theatrical in fiscal 2022 including ~~Doctor Strange in the Multiverse of Madness~~, ~~Lightyear, and~~ ~~Thor: Love and Thunder,~~ ~~and has committed to exclusive theatrical releases for several upcoming films including~~ ~~Black Panther: Wakanda Forever~~ ~~and~~ ~~Avatar: The Way of Water~~. The quantity of films ~~available for theatrical exhibition remains below pre-pandemic levels,~~released to theatres is also dependent upon the timing of film production by the studios. On May 2, 2023, the union representing script writers, the Writers Guild of America (WGA), went on strike after its contract expired with the Alliance of Motion Picture and Television Producers (AMPTP), which represents media companies including film studios. On July 14, 2023, the union representing actors, the Screen Actors Guild - American Federation of Television and Radio Artists (SAG-AFTRA), also went on strike over an ongoing labor dispute with AMPTP. Film production has ~~been impacted during fiscal 2022 by COVID-19 related disruptions, production delays resulting from supply chain disruptions~~stopped as a result of these strikes, and a ~~post-production backlog. While lead times for movie~~prolonged shutdown in film production ~~to theatrical~~may impact the film release ~~are lengthy, we expect to see increases~~schedule, particularly in ~~the quantity of available films in late 2023~~2024 and ~~2024.~~2025.

We ended the ~~third~~second quarter of fiscal ~~2022~~2023 with a total of 1,027 company-owned screens in 82 theatres, compared to 1,064 company-owned screens in 85 theatres ~~compared to 1,091 company-owned screens in 88 theatres~~ at the end of the ~~third~~second quarter of fiscal ~~2021. As of~~2022. Early in our fiscal 2023 first quarter, we made the ~~end of the third quarter of fiscal 2022 and the date of this report, all~~decision to close one of our ~~company-owned theatres are operating. As of the end of the third quarter of fiscal 2021 approximately 97% of our theatres were open and operating.~~owned theatres.

Hotels and Resorts

The following table sets forth revenues, operating income and operating margin for our hotels and resorts division for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 (in millions, except for variance percentage and operating margin):


		Third Quarter										First Three Quarters											Second Quarter										First Half
								Variance										Variance											Variance										Variance
		F2022			F2021			Amt.		Pct.		F2022			F2021			Amt.		Pct.			F2023			F2022			Amt.		Pct.		F2023			F2022			Amt.		Pct.
Revenues	Revenues	$	82.3		$	65.8		$	16.5	25.1	%	$	204.0		$	134.1		$	69.9	52.1	%	Revenues	$	70.1		$	69.0		$	1.1	1.5	%	$	125.9		$	121.7		$	4.2	3.5	%
Operating income	Operating income	14.1			13.5			0.7		4.9	%	18.0			5.5			12.5		227.3	%	Operating income	6.1			6.8			(0.7)		(10.4)	%	1.1			3.8			(2.8)		(72.1)	%
Operating margin (% of revenues)	Operating margin (% of revenues)	17.2		%	20.5		%					8.8		%	4.1		%					Operating margin (% of revenues)	8.7		%	9.9		%					0.9		%	3.2		%

On December 16, 2022, we completed the sale of The Skirvin Hilton in Oklahoma City, Oklahoma (we held a majority-ownership position in this hotel prior to its sale). The results of The Skirvin Hilton are included in our divisional and consolidated results of operations during fiscal 2022 through the date of the sale.

Excluding The Skirvin Hilton from fiscal 2022 results, hotels and resorts revenues increased 8.5% and 10.7% during the second quarter and first half of fiscal 2023 compared to the second quarter and first half of fiscal 2022, respectively. Our hotels and resorts division operating income during the ~~third~~second quarter and first ~~three quarters~~half of fiscal 2023 decreased compared to the second quarter and first half of fiscal 2022 due to the sale of The Skirvin Hilton (which had operating income during the first quarter and first half of fiscal 2022) and increased labor costs during the fiscal 2023 periods as we increased our staffing levels to enhance the customer experience compared to the ~~third~~second quarter and first three quarters of fiscal 2021, due to significantly increased revenues during the fiscal 2022 periods. All but one of our company-owned hotels and resorts contributed to the improved operating results during the third quarterhalf of fiscal 2022 ~~and all~~when various positions were unfilled due to staffing shortages.

Table of our company-owned hotels and resorts contributed to the improved operating results during the first three quarters of fiscal 2022 compared to the fiscal 2021 periods. Our fiscal 2021 third quarter and first three quarters operating income benefited from a state government grant totaling approximately $1.9 million.Contents

The following table provides a further breakdown of the components of revenues for the hotels and resorts division for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 (in millions, except for variance percentage):


		Third Quarter								First Three Quarters									Second Quarter								First Half
						Variance								Variance									Variance								Variance
		F2022		F2021		Amt.		Pct.		F2022		F2021		Amt.		Pct.			F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Room revenues	Room revenues	$	36.9	$	30.9	$	6.0	19.4	%	$	83.2	$	57.3	$	25.9	45.3	%	Room revenues	$	28.6	$	28.9	$	(0.2)	(0.8)	%	$	46.5	$	46.3	$	0.2	0.4	%
Food/beverage revenues	Food/beverage revenues	21.4		16.7		4.7		28.2	%	55.0		32.2		22.7		70.5	%	Food/beverage revenues	18.6		19.0		(0.4)		(2.3)	%	33.8		33.5		0.2		0.7	%
Other revenues	Other revenues	15.0		13.3		1.7		12.7	%	40.9		33.0		7.9		24.0	%	Other revenues	13.2		12.9		0.3		2.4	%	26.4		26.0		0.4		1.7	%
Total revenues before cost reimbursements	Total revenues before cost reimbursements	73.3		60.9		12.4		20.4	%	179.1		122.5		56.6		46.2	%	Total revenues before cost reimbursements	60.4		60.8		(0.4)		(0.6)	%	106.7		105.8		0.9		0.8	%
Cost reimbursements	Cost reimbursements	9.0		4.9		4.1		83.7	%	24.8		11.5		13.3		115.1	%	Cost reimbursements	9.7		8.3		1.4		17.2	%	19.2		15.9		3.3		21.0	%
Total revenues	Total revenues	$	82.3	$	65.8	$	16.5	25.1	%	$	204.0	$	134.1	$	69.9	52.1	%	Total revenues	$	70.1	$	69.0	$	1.1	1.5	%	$	125.9	$	121.7	$	4.2	3.5	%

Division total revenues increased significantly during the third quarter and first three quarters of fiscal 2022 compared to the third quarter and first three quarters of fiscal 2021. While all eight of our company-owned hotels and all but one of our managed hotels were open during the third quarter and first three quarters of fiscal 2021, the majority of these properties were generating significantly reduced revenues and operating under applicable state and local restrictions and guidelines, and, in some cases, reduced operating hours. In addition, we reopened our Milwaukee ~~SafeHouse~~ ~~restaurant and bar in June 2021 and reopened the Chicago~~ ~~SafeHouse~~ ~~in May 2022.~~

~~Table of Contents~~

We believe it is also beneficial to compare our revenues to pre-pandemic levels. The following table compares the components of revenues for the hotels and resorts division for the third quarter and first three quarters of fiscal 2022 to the third quarter and first three quarters of fiscal 2019 (in millions, except for variance percentage):

Third Quarter First Three Quarters
Variance Variance
F2022 F2019 Amt. Pct. F2022 F2019 Amt. Pct.
Room revenues $ 36.9 $ 34.2 $ 2.7 8.0 % $ 83.2 $ 81.3 $ 1.9 2.3 %
Food/beverage revenues 21.4 20.2 1.3 6.3 % 55.0 54.6 0.4 0.7 %
Other revenues 15.0 13.0 2.0 15.1 % 40.9 36.4 4.6 12.5 %
Total revenues before cost reimbursements 73.3 67.4 6.0 8.9 % 179.1 172.3 6.9 4.0 %
Cost reimbursements 9.0 7.2 1.8 24.3 % 24.8 27.3 (2.5) (9.2) %
Total revenues $ 82.3 $ 74.6 $ 7.7 10.4 % $ 204.0 $ 199.6 $ 4.4 2.2 %

Leisure travel continued to drive demand during the third quarter and first three quarters of fiscal 2022, representing an increased percentage of total rooms revenues compared to the fiscal 2019 periods. The leisure travel increase offset lower transient and group business revenues during the third quarter and first three quarters of fiscal 2022 compared to the same quarter and first three quarters of fiscal 2019. While business transient and group revenues as a percentage of total rooms revenues during the first three quarters of fiscal 2022 remains below fiscal 2019 levels, we have continued to see improvement in group revenues throughout fiscal 2022. The increase in group revenues during fiscal 2022 has consequently led to an increase in banquet and catering revenues, positively impacting our food and beverage revenues as compared to both fiscal 2021 and fiscal 2019 periods.

Other revenues increased during the third quarter and first three quarters of fiscal 2022 compared to the third quarter and first three quarters of fiscal 2019, primarily due to increased revenues from one of our condominium hotels and increased golf, ski and spa revenues at the Grand Geneva® ~~Resort & Spa (“Grand Geneva”), partially offset by decreased management fees. Cost~~before cost reimbursements decreased during the ~~first three quarters~~second quarter of fiscal 2023 compared to the second quarter of fiscal 2022, due to the negative impact of the sale of The Skirvin Hilton. Excluding The Skirvin Hilton from fiscal 2022 results, division revenues before cost reimbursements increased $4.1 million, or 7.2% during the second quarter of fiscal 2023 compared to the second quarter of fiscal 2022 due to increased occupancy at four of our seven owned hotels and increased average daily rate at six of our seven owned hotels. Division total revenues before cost reimbursements increased during the first half of fiscal 2023 compared to the first ~~three quarters~~half of fiscal ~~2019~~2022, despite the negative impact of the sale of the Skirvin Hilton, due to ~~a lower number~~increased occupancy at five of ~~managed~~our seven owned hotels and ~~reduced~~increased average daily rate at all seven of our owned hotels. Excluding The Skirvin Hilton from fiscal 2022 results, division revenues ~~and subsequent operating costs at our managed hotels.~~before cost reimbursements increased $8.9 million, or 9.0% during the first half of fiscal 2023 compared to the first half of fiscal 2022.

The following table sets forth certain operating statistics for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 and fiscal ~~2021,~~2022, including our average occupancy percentage (number of occupied rooms as a percentage of available rooms), our average daily room rate, or ADR, and our total revenue per available room, or RevPAR, for company-owned properties:

Third Quarter First Three Quarters
Variance Variance
F2022 F2021 Amt. Pct. F2022 F2021 Amt. Pct.
Occupancy pct. 74.7 % 64.9 % 9.8 pts 15.2 % 63.0 % 46.9 % 16.1 pts 34.4 %
ADR $ 202.78 $ 195.08 $ 7.70 3.9 % $ 179.90 $ 165.26 $ 14.64 8.9 %
RevPAR $ 151.55 $ 126.54 $ 25.01 19.8 % $ 113.38 $ 77.46 $ 35.92 46.4 %

Note: These operating statistics represent averages of our eight distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort. The statistics exclude days during fiscal 2021 where individual hotels may have been closed.

RevPAR increased at all but one of our eight company-owned properties during the third quarter of fiscal 2022 compared to the third quarter of fiscal 2021, and increased at all eight of our company-owned properties during the first three quarters of fiscal 2022 compared to the first three quarters of fiscal 2021. Leisure travel customers provided the most demand during the fiscal 2022 third quarter, with weekend business relatively strong at the majority of our properties. During the third quarter of fiscal 2022, our non-group business represented approximately 63% of our total rooms revenue, compared to approximately 59% during the third quarter of fiscal 2019 prior to the pandemic. Although group business continues to lag prior years, it has increased throughout fiscal 2022. Non-group retail pricing remained very strong in the majority of our markets during the third quarter of fiscal 2022, with significant leisure demand contributing to increased occupancy

~~Table of Contents~~

percentages and ADR. During the third quarter of fiscal 2021, our Milwaukee market hotels benefited from large demand drivers (Ryder Cup and Milwaukee Bucks playoffs) that did not recur in the third quarter of fiscal 2022.

We believe it is also beneficial to compare our operating statistics to pre-pandemic levels. The following table sets forth certain operating statistics for the third quarter and first three quarters of fiscal 2022 and fiscal 2019, including our average occupancy percentage, our ADR, and our RevPAR, for company-owned properties:


		Third Quarter										First Three Quarters											Second Quarter										First Half
								Variance										Variance											Variance										Variance
		F2022			F2019			Amt.		Pct.		F2022			F2019			Amt.		Pct.			F2023			F2022			Amt.		Pct.		F2023			F2022			Amt.		Pct.
Occupancy pct.	Occupancy pct.	75.0		%	83.0		%	(8.0) pts		(9.6)	%	63.6		%	75.2		%	(11.6) pts		(15.5)	%	Occupancy pct.	68.2		%	65.3		%	2.9 pts		4.5	%	59.5		%	55.7		%	3.8 pts		6.8	%
ADR	ADR	$	200.61		$	172.12		$	28.49	16.6	%	$	177.36		$	155.91		$	21.45	13.8	%	ADR	$	187.34		$	179.33		$	8.01	4.5	%	$	173.68		$	165.40		$	8.28	5.0	%
RevPAR	RevPAR	$	150.48		$	142.84		$	7.64	5.3	%	$	112.75		$	117.19		$	(4.44)	(3.8)	%	RevPAR	$	127.70		$	117.07		$	10.63	9.1	%	$	103.33		$	92.13		$	11.20	12.2	%

Note: These operating statistics represent averages of our seven distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort. The ~~statistics for both~~Skirvin Hilton is not included in the fiscal 2022 statistics.

RevPAR increased at all seven of our comparable company-owned properties during the second quarter and ~~2019 periods exclude the Saint Kate, which was closed during a significant portion~~first half of fiscal ~~2019.~~2023 compared to the second quarter and first half of fiscal 2022. Group demand continued to grow during the fiscal 2023 second quarter, with weekday and weekend growth increasing group as a percentage of our overall business mix. During the second quarter of fiscal 2023, our group business represented approximately 40% of our total rooms revenue, compared to approximately 38% during the second quarter of fiscal 2022. Non-group pricing remained strong in the majority of our markets during the second quarter of fiscal 2023, with leisure demand contributing to increased ADR.

According to data received from Smith Travel Research and compiled by us in order to evaluate our fiscal ~~2022 third~~2023 second quarter and first ~~three quarters~~half results, comparable “upper upscale” hotels—hotels identified as our industry— throughout the United States experienced an increase in RevPAR of ~~3.5%~~4.8% during our fiscal ~~2022 third~~2023 second quarter ~~and a decrease in RevPAR of 3.9% during our fiscal 2022 first three quarters~~ compared to the same ~~periods~~period during fiscal ~~2019,~~2022, leading us to believe we outperformed the industry during the fiscal ~~2022 third~~2023 second quarter ~~and first three quarters~~ by approximately ~~1.8 and 0.1~~4.3 percentage ~~points, respectively.~~ points. During the first half of fiscal 2023 compared to the first half of fiscal 2022, comparable “upper upscale” hotels experienced an increase in RevPAR of 14.4%, leading us to believe we underperformed the industry during the first half of fiscal 2023 by approximately 2.2 percentage points. We believe our underperformance during the first half of fiscal 2023 occurred because occupancy at our hotels recovered earlier in fiscal 2022, particularly in the first quarter of fiscal 2022, than the industry, which generally lagged our occupancy levels in fiscal 2022. This resulted

Table of Contents

in the industry growing occupancy at a faster rate than our owned hotels during the first half of fiscal 2023 compared to the prior year.

Data received from Smith Travel Research for our various “competitive sets”—hotels identified in our specific markets that we deem to be competitors to our hotels—indicates that these hotels experienced an increase in RevPAR of ~~3.9%~~10.1% during our ~~third~~second quarter, ~~and a decrease of 9.0% during our first three quarters of fiscal 2022,~~ again compared to the same ~~periods~~period in fiscal ~~2019.~~2022. Therefore, we believe we ~~outperformed~~underperformed our competitive sets during the ~~third~~second quarter of fiscal 2023 by approximately 1.0 percentage point. We believe our underperformance to our competitive sets during the second quarter of fiscal 2023 results primarily from a customer mix shift with an increase in the percentage of group business at lower daily rates and a decrease in the percentage of leisure customers at higher daily rates. During the first ~~three quarters~~half of fiscal 2023 compared to the first half of fiscal 2022, hotels in our competitive sets experienced an increase in RevPAR of 14.7%, leading us to believe we underperformed our competitive sets during the first half of fiscal 2023 by approximately ~~1.4~~2.5 percentage points. We believe our underperformance to our competitive sets during the first half of fiscal 2023 results primarily from the unfavorable customer mix shift during the second quarter of fiscal 2023 and ~~5.2 percentage points, respectively. Higher class segments~~because occupancy at our hotels recovered earlier in fiscal 2022, particularly in the first quarter of fiscal 2022, than our competitive sets, which generally lagged our occupancy levels in fiscal 2022. This resulted in our competitive sets growing occupancy at a faster rate than our owned hotels during the ~~hotel industry, such as luxury and upper upscale (with an increased reliance on business travel), continue to experience lower occupancies~~first half of fiscal 2023 compared to ~~lower class hotel segments such as economy and midscale.~~the prior year.

Looking to future periods, overall occupancy in the U.S. ~~continues~~is expected to continue to slowly ~~increase, in recent months reaching its highest level since the start of the pandemic.~~increase. In the near term, we expect ~~most demand will continue to come from the~~ leisure travel ~~segment.~~demand to normalize. Leisure travel in our markets has a seasonal component, peaking in the summer months and slowing down as children return to school and the weather turns colder. We are experiencing gradual increases in business travel as corporate training events, meetings, and conferences return and downtown offices reopen. ~~Our company-owned hotels have experienced a decrease in group bookings compared to pre-pandemic periods.~~ As of the date of this report, our group room revenue bookings for ~~the remainder of~~ fiscal ~~2022~~2023 - commonly referred to in the hotels and resorts industry as “group pace” - is running approximately ~~5% behind~~8% ahead of where we were at the same time last year. Group room revenue bookings for fiscal 2024 is running approximately 7% ahead of where we were at the same time in early fiscal ~~2019, but despite our reduced group pace as compared to the third quarter of fiscal 2019, our current group pace is an improvement from recent quarters. Group room revenue bookings~~2022 for fiscal ~~2023 is running approximately 18% behind where we were at the same time in fiscal 2019, which we believe is partially due to a shortening of the advance period for group bookings.~~2023. Banquet and catering revenue pace for fiscal ~~2022~~2023 and fiscal ~~2023~~2024 is similarly running ~~behind~~ahead of where we ~~would typically be~~were at this same time ~~of the year pre-pandemic. Overall, we generally expect our revenue~~last year. We are encouraged by continuing positive trends ~~to track or exceed the overall industry trends~~in group bookings for ~~our segment of the industry, particularly in our respective markets.~~fiscal 2023 and beyond.

Adjusted EBITDA

Adjusted EBITDA is a measure used by management and our board of directors to assess our financial performance and enterprise value. We believe that Adjusted EBITDA is a useful measure for us and investors, as it eliminates certain expenses that are not indicative of our core operating performance and facilitates a comparison of our core operating performance on a consistent basis from period to period. We also use Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.

~~Table of Contents~~

Adjusted EBITDA is a non-GAAP measure of our financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. Adjusted EBITDA has its limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP.

We define Adjusted EBITDA as net earnings (loss) attributable to The Marcus Corporation before investment income or loss, interest expense, other expense, gain or loss on disposition of property, equipment and other assets, equity earnings or losses from unconsolidated joint ventures, net earnings or losses attributable to noncontrolling interests, income taxes, ~~and~~ depreciation and amortization and non-cash share-based compensation expense, adjusted to eliminate the impact of certain items that we do not consider indicative of our core operating performance. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by us may not be comparable to the measures disclosed by other companies.

Table of Contents

The following table sets forth Adjusted EBITDA by reportable operating segment for the ~~third~~second quarter and first ~~three quarters~~half of fiscal ~~2022~~2023 and fiscal ~~2021~~2022 (in millions, except for variance percentage):


		Third Quarter								First Three Quarters									Second Quarter								First Half
						Variance								Variance									Variance								Variance
		F2022		F2021		Amt.		Pct.		F2022		F2021		Amt.		Pct.			F2023		F2022		Amt.		Pct.		F2023		F2022		Amt.		Pct.
Theatres	Theatres	$	12.5	$	10.6	$	1.8	17.4	%	$	46.0	$	(3.6)	$	49.6	1389.6	%	Theatres	$	31.3	$	28.8	$	2.5	8.7	%	$	45.1	$	33.5	$	11.5	34.4	%
Hotels and resorts	Hotels and resorts	19.1		17.0		2.1		12.2	%	33.3		20.0		13.3		66.2	%	Hotels and resorts	11.3		11.8		(0.5)		(4.2)	%	10.9		14.2		(3.3)		(23.2)	%
Corporate items	Corporate items	(3.7)		(3.1)		(0.6)		(18.7)	%	(10.8)		(10.6)		(0.1)		(1.1)	%	Corporate items	(3.9)		(3.3)		(0.6)		(18.4)	%	(7.8)		(7.1)		(0.7)		(10.2)	%
Total Adjusted EBITDA	Total Adjusted EBITDA	$	27.9	$	24.5	$	3.4	13.7	%	$	68.5	$	5.8	$	62.7	1075.2	%	Total Adjusted EBITDA	$	38.7	$	37.3	$	1.4	3.7	%	$	48.2	$	40.7	$	7.5	18.5	%

The following table sets forth our reconciliation of Adjusted EBITDA (in millions):

Third Quarter First Three Quarters
F2022 F2021 F2022 F2021
Net earnings (loss) attributable to The Marcus Corporation $ 3.3 $ 1.8 $ (2.7) $ (49.7)
Add (deduct):
Investment (income) loss — — 0.8 (0.2)
Interest expense 3.7 4.6 11.8 14.4
Other expense 0.4 0.6 1.5 1.9
Loss (gain) on disposition of property, equipment and other assets 0.1 (0.9) (0.3) (2.9)
Equity (earnings) losses from unconsolidated joint ventures — — 0.1 —
Income tax expense (benefit) 1.5 0.2 (0.3) (18.9)
Depreciation and amortization 16.5 17.7 50.4 54.2
Share-based compensation expenses (1)
2.5 2.5 7.0 6.7
Impairment charges (2)
— — — 3.7
Government grants (3)
— (2.0) — (3.3)
Total Adjusted EBITDA $ 27.9 $ 24.5 $ 68.5 $ 5.8

~~Table of Contents~~


	Second Quarter				First Half
	F2023		F2022		F2023		F2022
Net earnings (loss)	$	13.5	$	9.0	$	4.0	$	(5.9)
Add (deduct):
Investment (income) loss	(0.4)		0.5		(0.6)		0.7
Interest expense	3.1		4.1		6.1		8.2
Other (income) expense	0.5		0.6		0.9		1.2
Loss (gain) on disposition of property, equipment and other assets	0.4		0.1		0.8		(0.4)
Equity losses from unconsolidated joint ventures	—		—		0.2		0.1

Income tax expense (benefit)	4.1		4.8		1.3		(1.8)
Depreciation and amortization	16.0		16.8		31.9		34.0
Share-based compensation expenses (1)	1.5		1.7		3.7		4.6


Total Adjusted EBITDA	$	38.7	$	37.3	$	48.2	$	40.7

The following tables sets forth our reconciliation of Adjusted EBITDA by reportable operating segment (in millions):


		Third Quarter, F2022								First Three Quarters, F2022								Second Quarter, F2023								First Half, F2023
		Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total
Operating income (loss)	Operating income (loss)	$	(0.7)	$	14.1	$	(4.4)	$	8.9	$	7.7	$	18.0	$	(14.6)	11.0	Operating income (loss)	$	19.8	$	6.1	$	(5.1)	$	20.8	$	21.3	$	1.1	$	(10.6)	11.8
Depreciation and amortization	Depreciation and amortization	11.6		4.7		0.1		16.5		35.7		14.5		0.3		50.4	Depreciation and amortization	11.3		4.6		0.1		16.0		22.8		8.9		0.2		31.9
Loss (gain) on disposition of property, equipment and other assets																	Loss (gain) on disposition of property, equipment and other assets	—		0.4		—		0.4		0.3		0.5		—		0.8
Share-based compensation (1)	Share-based compensation (1)	1.5		0.2		0.7		2.5		2.6		0.8		3.6		7.0	Share-based compensation (1)	0.1		0.2		1.1		1.5		0.6		0.5		2.6		3.7

Total Adjusted EBITDA	Total Adjusted EBITDA	$	12.5	$	19.1	$	(3.7)	$	27.9	$	46.0	$	33.3	(10.8)		68.5	Total Adjusted EBITDA	$	31.3	$	11.3	$	(3.9)	$	38.7	$	45.1	$	10.9	(7.8)		48.2


		Third Quarter, F2021								First Three Quarters, F2021								Second Quarter, F2022								First Half, F2022
		Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total
Operating loss	Operating loss	$	(2.6)	$	13.5	$	(4.6)	$	6.3	$	(46.5)	$	5.5	$	(14.6)	(55.5)	Operating loss	$	16.4	$	6.8	$	(4.4)	$	18.9	$	8.4	$	3.8	$	(10.2)	2.1
Depreciation and amortization	Depreciation and amortization	12.6		5.0		0.1		17.7		38.8		15.2		0.2		54.2	Depreciation and amortization	11.9		4.8		0.1		16.8		24.1		9.8		0.2		34.0
Share-based compensation (1)	Share-based compensation (1)	0.6		0.5		1.4		2.5		1.7		1.3		3.7		6.7	Share-based compensation (1)	0.5		0.2		1.0		1.7		1.1		0.6		2.9		4.6
Impairment charges (2)		—		—		—		—		3.7		—		—		3.7
Government grants (3)		(0.1)		(1.9)		—		(2.0)		(1.3)		(1.9)		—		(3.3)
Total Adjusted EBITDA	Total Adjusted EBITDA	$	10.6	$	17.0	$	(3.1)	$	24.5	$	(3.6)	$	20.0	(10.6)		5.8	Total Adjusted EBITDA	$	28.8	$	11.8	$	(3.3)	$	37.3	$	33.5	$	14.2	$	(7.1)	$	40.7

(1)Non-cash expense related to share-based compensation programs.

~~(2)Non-cash impairment charges related to surplus theatre real estate.~~Table of Contents

~~(3)Reflects a nonrecurring state government grant awarded for COVID-19 pandemic relief.~~

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

Our movie theatre and hotels and resorts businesses, when open and operating normally, each generate significant and consistent daily amounts of cash, subject to previously-noted seasonality, because each segment’s revenue is derived predominantly from consumer cash purchases. Under normal circumstances, we believe that these relatively consistent and predictable cash sources, as well as the availability of unused credit lines, would be adequate to support the ongoing operational liquidity needs of our businesses.

Maintaining and protecting a strong balance sheet has always been a core value of The Marcus Corporation during our ~~87-year~~88-year history and ~~despite the COVID-19 pandemic,~~ our financial position remains strong. As of ~~September~~June 29, ~~2022,~~2023, we had a cash balance of approximately ~~$10.5~~$44.6 million, ~~$202.8~~$220.6 million of availability under our $225 million revolving credit facility, and our debt-to-capitalization ratio was ~~0.33.~~0.28. With our strong liquidity position combined with cash generated from operations, ~~and proceeds from the sale of surplus real estate (discussed above),~~ we believe we are positioned to meet our obligations as they come due and continue to sustain our operations throughout fiscal 2022 and fiscal 2023, even if our properties continue to generate reduced revenues during these periods. We will continue to work to preserve cash and maintain strong liquidity to endure the impacts of the global pandemic, even if it continues for a prolonged period of time.

~~We believe that the actions we have taken during the past two years will allow us~~ to have sufficient liquidity to meet our obligations as they come due and to comply with our debt covenants for at least 12 months from the issuance date of the consolidated financial ~~statements. However, future compliance with~~statements, as well as our debt covenants could be impacted if we are unable to continue operations as currently expected, which could be impacted by matters that are not entirely in our control, such as the reinstatement of protective actions that federal, state and local governments have taken and the timing of new movie releases (as described in the Impact of the COVID-19 Pandemic section of this MD&A and in our Annual Report for the year ended December 30, 2021). Future compliance with our debt covenants could also be impacted if the speed of recovery of our theatres and hotels and resorts businesses is slower than currently expected. For example, our current expectations are that our theatre division will continue to improve during fiscal 2023, but still report results below comparable periods in fiscal 2019. Our current expectations for our hotels and resorts division are that we will continue to show improvement during the remainder of fiscal 2022 and in fiscal 2023 compared to the prior year. We do not expect to

~~Table of Contents~~

return to pre-COVID-19 occupancy levels during fiscal 2022 due to an expected lag in business travel. It is possible that the impact of COVID-19 may be greater than currently expected across one or both of our divisions such that we may be unable to comply with our debt covenants in future periods. In such an event, we would either seek covenant waivers or attempt to amend our covenants, though there is no certainty that we would be successful in such efforts.longer-term capital requirements.

Financial Condition

Net cash provided by operating activities totaled ~~$60.4~~$47.3 million during the first ~~three quarters~~half of fiscal ~~2022,~~2023, compared to net cash provided by operating activities of ~~$2.1~~$55.2 million during the first ~~three quarters~~half of fiscal ~~2021.~~2022. The ~~$58.3~~$7.9 million ~~increase~~decrease in net cash provided by operating activities was due ~~primarily~~ to ~~a reduced net loss and~~ the ~~favorable timing in the collection of accounts receivable and~~ receipt of refundable income taxes of $22.7 million and government grants of $4.3 million during the first half of fiscal 2022 that did not recur in fiscal 2023, partially offset by ~~unfavorable~~an increase in net earnings and the favorable timing in the payment of accounts payable ~~accrued compensation~~ and other ~~accrued liabilities~~working capital payments during the first ~~three quarters~~half of fiscal 2023 compared to the first half of fiscal 2022.

Net cash used in investing activities during the first ~~three quarters~~half of fiscal ~~2022~~2023 totaled ~~$22.9~~$16.6 million, compared to net cash ~~provided by~~used in investing activities of ~~$9.2~~$11.5 million during the first ~~three quarters~~half of fiscal ~~2021.~~2022. The increase in net cash used in investing activities of ~~$32.1~~$5.2 million was the result of ~~an increase~~the impact of ~~$18.4~~the sale of non-core real estate assets of $4.8 million ~~in capital expenditures and the collection of an $11.4 million life insurance premium reimbursement~~ during the first ~~three quarters~~half of fiscal ~~2021~~2022 that did not recur in fiscal ~~2022.~~2023 and an increase in cash used in the purchase of trading securities and other investing activities, partially offset by a decrease of $0.4 million in capital expenditures. Total cash capital expenditures (including normal continuing capital maintenance and renovation projects) totaled ~~$27.5~~$15.9 million during the first ~~three quarters~~half of fiscal ~~2022~~2023 compared to ~~$9.1~~$16.3 million during the first ~~three quarters~~half of fiscal ~~2021.~~2022.

Fiscal ~~2022~~2023 first ~~three quarters~~half cash capital expenditures included approximately ~~$8.2~~$6.8 million incurred in our theatre division, primarily related to normal maintenance capital projects. We also incurred capital expenditures in our hotels and resorts division during the first ~~three quarters~~half of fiscal ~~2022~~2023 of approximately ~~$19.3~~$8.9 million, including costs related to ~~rooms~~guest room renovations at the Grand Geneva Resort and Spa and normal maintenance capital projects.

Net cash used in financing activities during the first ~~three quarters~~half of fiscal ~~2022~~2023 totaled ~~$44.8~~$6.3 million compared to net cash used in financing activities of ~~$10.4~~$4.4 million during the first ~~three quarters~~half of fiscal ~~2021.~~2022. During the first ~~three quarters~~half of fiscal ~~2022,~~2023, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As short-term revolving credit facility borrowings became due, we replaced them as necessary with new short-term revolving credit facility borrowings. As a result, we added ~~$62.0~~$38.0 million of new short-term revolving credit facility borrowings, and we made ~~$43.0~~$38.0 million of repayments on short-term revolving credit facility borrowings during the first ~~three quarters~~half of fiscal ~~2022~~2023 (net ~~increase in~~zero borrowings on our credit ~~facility of $19.0 million)~~facility). We ended the ~~third~~second quarter of fiscal ~~2022~~2023 with ~~$19.0 million of~~no outstanding borrowings under our revolving credit facility. During the first ~~three quarters~~half of fiscal ~~2021,~~2022, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As a result, we added ~~$128.5~~$22.0 million of new short-term revolving credit facility borrowings, and we made ~~$95.5~~$22.0 million of repayments on short-term revolving credit facility borrowings during the first ~~three quarters~~half of fiscal ~~2021~~2022 (net ~~increase in~~zero borrowings on our credit ~~facility of $33.0 million)~~facility).

~~During the first three quarters of fiscal 2022 we repaid $47.5 million of short-term term loan borrowings, compared to $37.8 million of such repayments during the first three quarters of fiscal 2021.~~ Principal payments on long-term debt were approximately ~~$11.3~~$0.8 million during the first ~~three quarters~~half of fiscal ~~2022~~2023 compared to payments of ~~$10.3~~$0.9 million during the first ~~three quarters~~half of fiscal ~~2021. During the first three quarters of fiscal 2021, we also received $6.7 million in proceeds from borrowings against the cash surrender value of a life insurance policy.~~2022. Our debt-to-capitalization ratio ~~(including short-term borrowings but excluding~~(excluding our finance and operating lease obligations) was ~~0.33~~0.28 at ~~September~~June 29, ~~2022,~~2023, compared to ~~0.37~~0.28 at December ~~30, 2021.~~

~~During the third quarter of fiscal 2022, on July~~ 29, ~~2022 we repaid $46.6 million of short-term borrowings, repaying in full and retiring the term loan facility maturing on September 22,~~ 2022. In connection with the repayment of the term loan, the Company amended the Credit Agreement by entering into the Fourth Amendment which modified the consolidated fixed charge coverage covenant, reducing the requirement to maintain a consolidated fixed charge coverage ratio of at least 3.0 to 1.0 to at least 2.5 to 1.0 starting as of the end of the fiscal quarter ending March 30, 2023 and continuing for each fiscal quarter thereafter.

During the first ~~three quarters~~half of fiscal ~~2022~~2023 and the first ~~three quarters~~half of fiscal ~~2021~~2022, we did not repurchase any shares of our common stock in the open market. As of ~~September~~June 29, ~~2022,~~2023, approximately 2.5 million shares remained available for repurchase under prior

2822

Table of Contents

~~repurchase under prior~~ Board of Directors repurchase authorizations. Under these authorizations, we may repurchase shares of our common stock from time to time in the open market, pursuant to privately-negotiated transactions or otherwise, depending upon a number of factors, including prevailing market conditions.

~~During~~Dividends paid during the ~~third quarter~~first half of fiscal 2022, on July 29, 2022 the Board of Directors elected to reinstate our quarterly dividend that had been suspended as a result of the COVID-19 pandemic, declaring a regular quarterly cash dividend of $0.05 per share of common stock. The dividend was paid on September 15, 2022 to shareholders of record on August 25, 2022. The Board of Directors also declared a dividend of $0.045 per share on the Class B common stock. The dividend on the Class B common stock, which is not publicly traded, was paid on September 15, 2022 to shareholders of record on August 25, 2022.2023 were $3.1 million. We did not make any dividend payments during the first ~~three quarters~~half of fiscal ~~2021.~~

2022. Our Credit Agreement, as amended, required us to temporarily suspend our quarterly dividend payments and prohibited us from repurchasing shares of our common stock in the open market during fiscal 2021. The Credit Agreement also limitslimited the total amount of quarterly dividend payments or share repurchases during ~~the four subsequent quarters beginning with the first quarter of~~ fiscal 2022 to no more than $1.55 million per quarter. Beginning with the first quarter ~~unless~~of fiscal 2023, we ~~are in~~returned to compliance with prior financial covenants under the Credit Agreement that were temporarily waived (specifically, the consolidated fixed charge coverage ratio), ~~at which point we~~removing any limitations on the total amount of quarterly dividends or share repurchases. We have the ability to declare quarterly dividend payments and/or repurchase shares of our common stock in the open market as we deem appropriate.

During the first quarter of fiscal 2023, we amended the Credit Agreement by entering into the Fifth Amendment effective on February 10, 2023, which replaced the variable rate LIBOR benchmark with the secured overnight financing rate (“SOFR”). Borrowings under the Credit Agreement now generally bear interest at a variable rate equal to: (i) SOFR plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon our consolidated debt to capitalization ratio as of the most recent determination date; or (ii) the base rate (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon our consolidated debt to capitalization ratio as of the most recent determination date. In addition, the Credit Agreement generally requires us to pay a facility fee equal to 0.125% to 0.25% of the total revolving commitment, depending on our consolidated debt to capitalization ratio, as defined in the Credit Agreement.

Critical Accounting Policies and Estimates

We have included a summary of our Critical Accounting Policies and Estimates in our Annual Report on Form 10-K for the year ended December 29, 2022. There have been no material changes to the summary provided in that report.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We have not experienced any material changes in our market risk exposures since December ~~30, 2021.~~29, 2022.

Item 4. Controls and Procedures

a.Evaluation of disclosure controls and procedures

Based on their evaluations and the evaluation of management, as of the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

b.Changes in internal control over financial reporting

There were no significant changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15 of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2923

Table of Contents

PART II – OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December ~~30, 2021.~~29, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth information with respect to purchases made by us or on our behalf of our Common Stock during the periods indicated.

Period Total Number of
Shares
Purchased Average Price
Paid per Share Total Number of
Shares
Purchased as
Part of Publicly
Announced
Programs (1) Maximum
Number of
Shares that May
Yet be Purchased
Under the Plans
or Programs (1)
July 1 - July 28 46,659 $ 15.51 46,659 2,527,808
July 29 - September 1 5,162 16.43 5,162 2,522,646
September 2 - September 29 — — — 2,522,646
Total 51,821 $ 15.60 51,821 2,522,646


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs (1)	Maximum Number of Shares that May Yet be Purchased Under the Plans or Programs (1)
March 31 - April 27	—	$	—	—	2,502,788
April 28 - June 1	13,877	15.96		13,877	2,488,911
June 2 - June 29	—	—		—	2,488,911
Total	13,877	$	15.74	13,877	2,488,911

(1)Through ~~September~~June 29, ~~2022,~~2023, our Board of Directors had authorized the repurchase of up to approximately 11.7 million shares of our outstanding Common Stock. Under these authorizations, we may repurchase shares of our Common Stock from time to time in the open market, pursuant to privately negotiated transactions or otherwise. As of ~~September~~June 29, ~~2022,~~2023, we had repurchased approximately 9.2 million shares of our Common Stock under these authorizations. The repurchased shares are held in our treasury pending potential future issuance in connection with employee benefit, option or stock ownership plans or other general corporate purposes. These authorizations do not have an expiration date. The shares purchased during the ~~third~~second quarter of 2022 were purchased in conjunction with the exercise of stock options pursuant to the publicly announced repurchase authorization.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

[During the thirteen weeks ended June 29, 2023, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.]

Table of Contents

Item 6. Exhibits



~~4.1~~10.1			~~Fourth Amendment to Credit~~Employee Advisory Services Agreement, dated ~~July 29, 2022, among~~May 23, 2023, between the ~~Marcus Corporation, the lenders party thereto~~Company and ~~JPMorgan Chase Bank, N.A., as Administrative Agent. [Schedules and exhibits have been omitted and the Marcus Corporation agrees~~Stephen H. Marcus. [Incorporated by reference to ~~furnish supplementally~~Exhibit 10.1 to ~~the Securities and Exchange Commission a Copy of any ommitted schedules and exhibits upon request.~~our Current Report on Form 8-K dated May 23, 2023.]


31.1			Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2			Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32			Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350.

101.INS			The instance document does not appear in the interactive data file because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document.

101.SCH			Inline XBRL Taxonomy Extension Schema Document.

101.CAL			Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF			Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB			Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE			Inline XBRL Taxonomy Extension Presentation Linkbase Document

104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

3025

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


THE MARCUS CORPORATION

DATE: ~~November 3, 2022~~August 2, 2023	By:	/s/ Gregory S. Marcus
		Gregory S. Marcus
		President and Chief Executive Officer


DATE: ~~November 3, 2022~~August 2, 2023	By:	/s/ Chad M. Paris
		Chad M. Paris
		Chief Financial Officer and Treasurer

S-1


		Page
PART I – FINANCIAL INFORMATION

Item 1.	Consolidated Financial ~~Statements:~~Statements (Unaudited):

	Consolidated Balance Sheets	3

	Consolidated Statements of Earnings (Loss)	5

	Consolidated Statements of Comprehensive Income (Loss)	6

	Consolidated Statements of Cash Flows	7

	Condensed Notes to Consolidated Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	1614

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2923

Item 4.	Controls and Procedures	2923

PART II – OTHER INFORMATION

Item 1A.	Risk Factors	3024

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3024

Item 4.	Mine Safety Disclosures	3024

Item 6.	Exhibits	3025

	Signatures	S-1